| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.67 | 0.005 | 0.682 | Anticonvulsant | 0.682 0.005 DBMET00291 0.276 0.047 DBMET00804 0.399 0.022 DBMET00710 0.17 0.107 DBMET00806 0.441 0.017 DBMET00681 0.379 0.024 DBMET01101 0.379 0.024 DBMET02601 0.379 0.024 DBMET02600 | DBMET00291 | |
| 0.606 | 0.007 | 0.746 | GABA C receptor rho-3 antagonist | 0.444 0.044 DBMET00291 0.429 0.05 DBMET00804 0.646 0.004 DBMET00710 0.428 0.05 DBMET00806 0.606 0.007 DBMET00681 0.576 0.01 DBMET01101 0.746 0.002 DBMET00684 0.576 0.01 DBMET02601 0.576 0.01 DBMET02600 | DBMET00684 | |
| 0.572 | 0.004 | 0.572 | Interleukin 1 antagonist | 0.364 0.008 DBMET00291 0.475 0.005 DBMET00804 0.435 0.005 DBMET00710 0.431 0.005 DBMET00681 0.444 0.005 DBMET01101 0.194 0.035 DBMET00684 0.444 0.005 DBMET02601 0.444 0.005 DBMET02600 | ||
| 0.562 | 0.013 | 0.562 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.484 0.041 DBMET00291 0.436 0.071 DBMET00804 0.441 0.068 DBMET00710 0.434 0.073 DBMET00806 0.441 0.068 DBMET00681 0.42 0.084 DBMET01101 0.521 0.025 DBMET00684 0.42 0.084 DBMET02601 0.42 0.084 DBMET02600 | ||
| 0.517 | 0.007 | 0.528 | Anesthetic general | 0.404 0.016 DBMET00291 0.334 0.026 DBMET00804 0.5 0.008 DBMET00710 0.412 0.015 DBMET00806 0.528 0.006 DBMET00681 0.485 0.009 DBMET01101 0.285 0.037 DBMET00684 0.485 0.009 DBMET02601 0.485 0.009 DBMET02600 | DBMET00681 | |
| 0.532 | 0.041 | 0.532 | Analgesic | 0.468 0.059 DBMET00291 0.226 0.207 DBMET00804 0.382 0.092 DBMET00710 0.415 0.078 DBMET00681 0.305 0.138 DBMET01101 0.305 0.138 DBMET02601 0.305 0.138 DBMET02600 | ||
| 0.499 | 0.01 | 0.743 | Peroxidase inhibitor | 0.29 0.039 DBMET00291 0.269 0.043 DBMET00804 0.611 0.004 DBMET00710 0.355 0.027 DBMET00806 0.647 0.004 DBMET00681 0.608 0.004 DBMET01101 0.743 0.002 DBMET00684 0.608 0.004 DBMET02601 0.608 0.004 DBMET02600 | DBMET00684 | |
| 0.484 | 0.021 | 0.484 | Interleukin antagonist | 0.402 0.03 DBMET00291 0.38 0.034 DBMET00804 0.482 0.021 DBMET00710 0.471 0.022 DBMET00681 0.441 0.025 DBMET01101 0.387 0.033 DBMET00684 0.441 0.025 DBMET02601 0.441 0.025 DBMET02600 | ||
| 0.49 | 0.029 | 0.788 | 5 Hydroxytryptamine release stimulant | 0.421 0.042 DBMET00291 0.288 0.074 DBMET00804 0.447 0.037 DBMET00710 0.379 0.05 DBMET00806 0.525 0.023 DBMET00681 0.389 0.048 DBMET01101 0.788 0.004 DBMET00684 0.389 0.048 DBMET02601 0.389 0.048 DBMET02600 | DBMET00684 | |
| 0.451 | 0.04 | 0.475 | Angiogenesis inhibitor | 0.435 0.043 DBMET00291 0.197 0.174 DBMET00804 0.43 0.045 DBMET00710 0.378 0.06 DBMET00681 0.475 0.034 DBMET01101 0.221 0.147 DBMET00684 0.475 0.034 DBMET02601 0.475 0.034 DBMET02600 | DBMET02600 | |
| 0.391 | 0.028 | 0.65 | Superoxide dismutase inhibitor | 0.212 0.105 DBMET00291 0.191 0.128 DBMET00804 0.423 0.023 DBMET00710 0.418 0.024 DBMET00806 0.474 0.016 DBMET00681 0.451 0.019 DBMET01101 0.65 0.005 DBMET00684 0.451 0.019 DBMET02601 0.451 0.019 DBMET02600 | DBMET00684 | |
| 0.386 | 0.049 | 0.858 | Aldehyde oxidase inhibitor | 0.231 0.09 DBMET00291 0.164 0.127 DBMET00804 0.561 0.024 DBMET00710 0.638 0.014 DBMET00806 0.627 0.015 DBMET00681 0.555 0.025 DBMET01101 0.858 0.004 DBMET00684 0.555 0.025 DBMET02601 0.555 0.025 DBMET02600 | DBMET00684 | |
| 0.345 | 0.01 | 0.345 | Nav1.2 sodium channel blocker | 0.229 0.026 DBMET00291 0.28 0.017 DBMET00804 0.265 0.019 DBMET00710 0.121 0.082 DBMET00806 0.268 0.019 DBMET00681 0.209 0.031 DBMET01101 0.122 0.081 DBMET00684 0.209 0.031 DBMET02601 0.209 0.031 DBMET02600 | ||
| 0.341 | 0.018 | 0.679 | Tyrosine 3 hydroxylase inhibitor | 0.258 0.06 DBMET00291 0.225 0.097 DBMET00804 0.395 0.009 DBMET00710 0.27 0.052 DBMET00806 0.395 0.009 DBMET00681 0.362 0.014 DBMET01101 0.679 0.003 DBMET00684 0.362 0.014 DBMET02601 0.362 0.014 DBMET02600 | DBMET00684 | |
| 0.428 | 0.123 | 0.504 | Antiinflammatory | 0.383 0.149 DBMET00291 0.326 0.192 DBMET00804 0.434 0.119 DBMET00710 0.48 0.096 DBMET00681 0.504 0.086 DBMET01101 0.504 0.086 DBMET02601 0.504 0.086 DBMET02600 | DBMET02600 | |
| 0.331 | 0.032 | 0.424 | 5 Hydroxytryptamine uptake stimulant | 0.296 0.047 DBMET00291 0.248 0.083 DBMET00804 0.297 0.047 DBMET00710 0.263 0.069 DBMET00806 0.325 0.034 DBMET00681 0.339 0.029 DBMET01101 0.424 0.01 DBMET00684 0.339 0.029 DBMET02601 0.339 0.029 DBMET02600 | DBMET00684 | |
| 0.296 | 0.008 | 0.296 | Ferrochelatase inhibitor | 0.145 0.04 DBMET00291 0.123 0.052 DBMET00804 0.144 0.04 DBMET00710 0.146 0.039 DBMET00806 0.144 0.04 DBMET00681 0.144 0.04 DBMET01101 0.293 0.008 DBMET00684 0.144 0.04 DBMET02601 0.144 0.04 DBMET02600 | ||
| 0.303 | 0.028 | 0.336 | Non-steroidal antiinflammatory agent | 0.199 0.072 DBMET00291 0.174 0.092 DBMET00804 0.297 0.029 DBMET00710 0.336 0.021 DBMET00681 0.322 0.024 DBMET01101 0.196 0.074 DBMET00684 0.322 0.024 DBMET02601 0.322 0.024 DBMET02600 | DBMET00681 | |
| 0.364 | 0.104 | 0.581 | 5 Hydroxytryptamine release inhibitor | 0.251 0.227 DBMET00291 0.354 0.112 DBMET00710 0.415 0.069 DBMET00806 0.39 0.085 DBMET00681 0.311 0.153 DBMET01101 0.581 0.014 DBMET00684 0.311 0.153 DBMET02601 0.311 0.153 DBMET02600 | DBMET00684 | |
| 0.274 | 0.015 | 0.274 | MAP kinase kinase 3 inhibitor | 0.214 0.086 DBMET00291 0.22 0.075 DBMET00804 0.213 0.088 DBMET00710 0.213 0.088 DBMET00681 0.213 0.088 DBMET01101 0.195 0.137 DBMET00684 0.213 0.088 DBMET02601 0.213 0.088 DBMET02600 | ||
| 0.319 | 0.062 | 0.486 | Lipoxygenase inhibitor | 0.232 0.112 DBMET00291 0.196 0.145 DBMET00804 0.438 0.029 DBMET00710 0.486 0.02 DBMET00681 0.479 0.022 DBMET01101 0.364 0.047 DBMET00684 0.479 0.022 DBMET02601 0.479 0.022 DBMET02600 | DBMET00681 | |
| 0.358 | 0.111 | 0.617 | Calcium channel L-type activator | 0.5 0.028 DBMET00710 0.257 0.197 DBMET00806 0.441 0.056 DBMET00681 0.444 0.054 DBMET01101 0.617 0.005 DBMET00684 0.444 0.054 DBMET02601 0.444 0.054 DBMET02600 | DBMET00684 | |
| 0.256 | 0.01 | 0.516 | GABA C receptor rho-2 antagonist | 0.164 0.056 DBMET00291 0.154 0.068 DBMET00804 0.267 0.009 DBMET00710 0.171 0.05 DBMET00806 0.251 0.011 DBMET00681 0.238 0.014 DBMET01101 0.516 0.003 DBMET00684 0.238 0.014 DBMET02601 0.238 0.014 DBMET02600 | DBMET00684 | |
| 0.284 | 0.045 | 0.324 | Gastrin inhibitor | 0.205 0.141 DBMET00291 0.237 0.096 DBMET00710 0.324 0.019 DBMET00806 0.217 0.123 DBMET00681 0.218 0.122 DBMET01101 0.265 0.063 DBMET00684 0.218 0.122 DBMET02601 0.218 0.122 DBMET02600 | DBMET00806 | |
| 0.252 | 0.013 | 0.294 | GABA C receptor agonist | 0.129 0.044 DBMET00291 0.099 0.068 DBMET00804 0.184 0.024 DBMET00710 0.159 0.031 DBMET00806 0.184 0.024 DBMET00681 0.184 0.024 DBMET01101 0.294 0.01 DBMET00684 0.184 0.024 DBMET02601 0.184 0.024 DBMET02600 | DBMET00684 | |
| 0.282 | 0.05 | 0.294 | DNA synthesis inhibitor | 0.274 0.054 DBMET00291 0.229 0.084 DBMET00804 0.287 0.048 DBMET00710 0.294 0.046 DBMET00806 0.285 0.049 DBMET00681 0.267 0.057 DBMET01101 0.262 0.059 DBMET00684 0.267 0.057 DBMET02601 0.267 0.057 DBMET02600 | DBMET00806 | |
| 0.311 | 0.081 | 0.461 | Calcium channel activator | 0.233 0.168 DBMET00291 0.309 0.083 DBMET00710 0.289 0.103 DBMET00806 0.288 0.104 DBMET00681 0.276 0.117 DBMET01101 0.461 0.009 DBMET00684 0.276 0.117 DBMET02601 0.276 0.117 DBMET02600 | DBMET00684 | |
| 0.244 | 0.019 | 0.267 | 5 Hydroxytryptamine 3E antagonist | 0.202 0.059 DBMET00291 0.183 0.099 DBMET00804 0.187 0.088 DBMET00710 0.164 0.158 DBMET00806 0.197 0.067 DBMET00681 0.183 0.097 DBMET01101 0.267 0.01 DBMET00684 0.183 0.097 DBMET02601 0.183 0.097 DBMET02600 | DBMET00684 | |
| 0.231 | 0.019 | 0.231 | Platelet activating factor beta antagonist | 0.177 0.03 DBMET00710 0.14 0.041 DBMET00681 0.203 0.024 DBMET01101 0.203 0.024 DBMET02601 0.203 0.024 DBMET02600 | ||
| 0.232 | 0.023 | 0.232 | Sodium channel blocker | 0.108 0.1 DBMET00291 0.117 0.088 DBMET00804 0.143 0.063 DBMET00710 0.162 0.049 DBMET00681 0.134 0.07 DBMET01101 0.134 0.07 DBMET02601 0.134 0.07 DBMET02600 | ||
| 0.211 | 0.007 | 0.318 | GABA C receptor rho-1 antagonist | 0.128 0.034 DBMET00291 0.113 0.046 DBMET00804 0.203 0.008 DBMET00710 0.118 0.042 DBMET00806 0.186 0.01 DBMET00681 0.18 0.012 DBMET01101 0.318 0.003 DBMET00684 0.18 0.012 DBMET02601 0.18 0.012 DBMET02600 | DBMET00684 | |
| 0.252 | 0.051 | 0.306 | Platelet aggregation inhibitor | 0.291 0.038 DBMET00291 0.185 0.093 DBMET00804 0.251 0.051 DBMET00710 0.207 0.077 DBMET00806 0.203 0.079 DBMET00681 0.306 0.034 DBMET01101 0.306 0.034 DBMET02601 0.306 0.034 DBMET02600 | DBMET02600 | |
| 0.262 | 0.062 | 0.341 | 5 Hydroxytryptamine 1E antagonist | 0.233 0.093 DBMET00710 0.261 0.063 DBMET00681 0.233 0.093 DBMET01101 0.341 0.012 DBMET00684 0.233 0.093 DBMET02601 0.233 0.093 DBMET02600 | DBMET00684 | |
| 0.211 | 0.012 | 0.25 | 5 Hydroxytryptamine 3A agonist | 0.112 0.063 DBMET00291 0.171 0.025 DBMET00710 0.117 0.058 DBMET00806 0.199 0.015 DBMET00681 0.153 0.034 DBMET01101 0.25 0.005 DBMET00684 0.153 0.034 DBMET02601 0.153 0.034 DBMET02600 | DBMET00684 | |
| 0.208 | 0.011 | 0.43 | Porphobilinogen synthase inhibitor | 0.218 0.01 DBMET00710 0.093 0.039 DBMET00806 0.218 0.01 DBMET00681 0.19 0.013 DBMET01101 0.43 0.004 DBMET00684 0.19 0.013 DBMET02601 0.19 0.013 DBMET02600 | DBMET00684 | |
| 0.207 | 0.012 | 0.351 | GABA C receptor antagonist | 0.144 0.033 DBMET00291 0.126 0.047 DBMET00804 0.203 0.012 DBMET00710 0.124 0.049 DBMET00806 0.184 0.016 DBMET00681 0.183 0.017 DBMET01101 0.351 0.004 DBMET00684 0.183 0.017 DBMET02601 0.183 0.017 DBMET02600 | DBMET00684 | |
| 0.217 | 0.023 | 0.217 | Sodium channel (voltage-gated) blocker | 0.111 0.096 DBMET00291 0.111 0.096 DBMET00804 0.133 0.069 DBMET00710 0.151 0.053 DBMET00681 0.13 0.074 DBMET01101 0.13 0.074 DBMET02601 0.13 0.074 DBMET02600 | ||
| 0.197 | 0.006 | 0.354 | NMDA 2B receptor antagonist | 0.06 0.031 DBMET00291 0.219 0.005 DBMET00710 0.354 0.004 DBMET00806 0.209 0.005 DBMET00681 0.175 0.007 DBMET01101 0.084 0.02 DBMET00684 0.175 0.007 DBMET02601 0.175 0.007 DBMET02600 | DBMET00806 | |
| 0.206 | 0.02 | 0.206 | Butyrylcholinesterase inhibitor | 0.133 0.041 DBMET00710 0.102 0.06 DBMET00806 0.161 0.03 DBMET00681 0.148 0.035 DBMET01101 0.095 0.066 DBMET00684 0.148 0.035 DBMET02601 0.148 0.035 DBMET02600 | ||
| 0.193 | 0.007 | 0.388 | Alcohol oxidase inhibitor | 0.072 0.028 DBMET00291 0.064 0.033 DBMET00804 0.327 0.004 DBMET00710 0.184 0.007 DBMET00806 0.327 0.004 DBMET00681 0.169 0.008 DBMET01101 0.388 0.004 DBMET00684 0.169 0.008 DBMET02601 0.169 0.008 DBMET02600 | DBMET00684 | |
| 0.272 | 0.088 | 0.295 | Immunostimulant | 0.258 0.093 DBMET00291 0.209 0.115 DBMET00804 0.286 0.083 DBMET00710 0.257 0.093 DBMET00806 0.295 0.08 DBMET00681 0.266 0.09 DBMET01101 0.211 0.114 DBMET00684 0.266 0.09 DBMET02601 0.266 0.09 DBMET02600 | DBMET00681 | |
| 0.204 | 0.023 | 0.351 | Cystathionine beta-synthase inhibitor | 0.145 0.043 DBMET00291 0.131 0.05 DBMET00804 0.293 0.01 DBMET00710 0.225 0.019 DBMET00806 0.34 0.007 DBMET00681 0.301 0.009 DBMET01101 0.351 0.006 DBMET00684 0.301 0.009 DBMET02601 0.301 0.009 DBMET02600 | DBMET00684 | |
| 0.264 | 0.084 | 0.345 | Insulysin inhibitor | 0.259 0.088 DBMET00710 0.242 0.104 DBMET00806 0.273 0.077 DBMET00681 0.254 0.092 DBMET01101 0.345 0.036 DBMET00684 0.254 0.092 DBMET02601 0.254 0.092 DBMET02600 | DBMET00684 | |
| 0.233 | 0.061 | 0.331 | RNA-directed DNA polymerase inhibitor | 0.198 0.103 DBMET00291 0.171 0.15 DBMET00804 0.248 0.05 DBMET00710 0.249 0.05 DBMET00806 0.237 0.058 DBMET00681 0.271 0.039 DBMET01101 0.331 0.026 DBMET00684 0.271 0.039 DBMET02601 0.271 0.039 DBMET02600 | DBMET00684 | |
| 0.252 | 0.079 | 0.36 | DNA damaging | 0.248 0.081 DBMET00291 0.292 0.06 DBMET00710 0.25 0.08 DBMET00806 0.281 0.065 DBMET00681 0.335 0.045 DBMET01101 0.36 0.038 DBMET00684 0.335 0.045 DBMET02601 0.335 0.045 DBMET02600 | DBMET00684 | |
| 0.296 | 0.126 | 0.551 | Histamine release inhibitor | 0.208 0.193 DBMET00291 0.363 0.094 DBMET00710 0.295 0.126 DBMET00806 0.4 0.076 DBMET00681 0.392 0.08 DBMET01101 0.551 0.016 DBMET00684 0.392 0.08 DBMET02601 0.392 0.08 DBMET02600 | DBMET00684 | |
| 0.201 | 0.034 | 0.399 | Alpha-N-acetylglucosaminidase inhibitor | 0.143 0.059 DBMET00291 0.11 0.088 DBMET00804 0.137 0.063 DBMET00710 0.399 0.009 DBMET00806 0.137 0.063 DBMET00681 0.137 0.063 DBMET01101 0.261 0.021 DBMET00684 0.137 0.063 DBMET02601 0.137 0.063 DBMET02600 | DBMET00806 | |
| 0.184 | 0.018 | 0.212 | Adenylate kinase inhibitor | 0.133 0.034 DBMET00291 0.115 0.048 DBMET00804 0.139 0.031 DBMET00710 0.212 0.013 DBMET00806 0.139 0.031 DBMET00681 0.139 0.031 DBMET01101 0.162 0.023 DBMET00684 0.139 0.031 DBMET02601 0.139 0.031 DBMET02600 | DBMET00806 | |
| 0.244 | 0.083 | 0.313 | Interleukin agonist | 0.161 0.157 DBMET00291 0.203 0.118 DBMET00710 0.313 0.042 DBMET00806 0.223 0.1 DBMET00681 0.219 0.104 DBMET01101 0.291 0.053 DBMET00684 0.219 0.104 DBMET02601 0.219 0.104 DBMET02600 | DBMET00806 | |
| 0.182 | 0.022 | 0.186 | Sphingosine 1-phosphate receptor 5 antagonist | 0.169 0.034 DBMET00710 0.172 0.031 DBMET00681 0.17 0.033 DBMET01101 0.186 0.019 DBMET00684 0.17 0.033 DBMET02601 0.17 0.033 DBMET02600 | DBMET00684 | |
| 0.173 | 0.016 | 0.389 | Creatine kinase inhibitor | 0.118 0.043 DBMET00291 0.111 0.049 DBMET00804 0.306 0.004 DBMET00710 0.166 0.018 DBMET00806 0.293 0.004 DBMET00681 0.302 0.004 DBMET01101 0.389 0.003 DBMET00684 0.302 0.004 DBMET02601 0.302 0.004 DBMET02600 | DBMET00684 | |
| 0.203 | 0.047 | 0.259 | Succinate dehydrogenase inhibitor | 0.176 0.073 DBMET00291 0.152 0.108 DBMET00804 0.2 0.049 DBMET00710 0.178 0.07 DBMET00806 0.216 0.038 DBMET00681 0.224 0.033 DBMET01101 0.259 0.019 DBMET00684 0.224 0.033 DBMET02601 0.224 0.033 DBMET02600 | DBMET00684 | |
| 0.184 | 0.028 | 0.184 | Cathepsin H inhibitor | 0.139 0.055 DBMET00291 0.134 0.06 DBMET00804 0.139 0.055 DBMET00710 0.137 0.057 DBMET00806 0.139 0.055 DBMET00681 0.118 0.078 DBMET01101 0.158 0.041 DBMET00684 0.118 0.078 DBMET02601 0.118 0.078 DBMET02600 | ||
| 0.169 | 0.027 | 0.169 | GABA receptor agonist | 0.125 0.052 DBMET00710 0.129 0.049 DBMET00681 0.126 0.052 DBMET01101 0.16 0.031 DBMET00684 0.126 0.052 DBMET02601 0.126 0.052 DBMET02600 | ||
| 0.165 | 0.028 | 0.165 | Nav1.4 sodium channel blocker | 0.119 0.053 DBMET00291 0.111 0.061 DBMET00804 0.159 0.03 DBMET00710 0.159 0.03 DBMET00681 0.13 0.044 DBMET01101 0.111 0.062 DBMET00684 0.13 0.044 DBMET02601 0.13 0.044 DBMET02600 | ||
| 0.178 | 0.042 | 0.396 | NADPH oxidase inhibitor | 0.26 0.019 DBMET00710 0.137 0.064 DBMET00806 0.26 0.019 DBMET00681 0.284 0.015 DBMET01101 0.396 0.005 DBMET00684 0.284 0.015 DBMET02601 0.284 0.015 DBMET02600 | DBMET00684 | |
| 0.151 | 0.016 | 0.151 | MAP kinase kinase 1 inhibitor | 0.128 0.028 DBMET00291 0.145 0.018 DBMET00710 0.113 0.042 DBMET00806 0.137 0.022 DBMET00681 0.139 0.021 DBMET01101 0.115 0.04 DBMET00684 0.139 0.021 DBMET02601 0.139 0.021 DBMET02600 | ||
| 0.142 | 0.008 | 0.149 | Purinergic P2X1 antagonist | 0.101 0.016 DBMET00291 0.086 0.022 DBMET00804 0.146 0.008 DBMET00710 0.149 0.007 DBMET00806 0.146 0.008 DBMET00681 0.137 0.009 DBMET01101 0.11 0.014 DBMET00684 0.137 0.009 DBMET02601 0.137 0.009 DBMET02600 | DBMET00806 | |
| 0.158 | 0.024 | 0.178 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.127 0.035 DBMET00291 0.096 0.058 DBMET00804 0.112 0.044 DBMET00710 0.178 0.02 DBMET00806 0.112 0.044 DBMET00681 0.101 0.053 DBMET01101 0.163 0.023 DBMET00684 0.101 0.053 DBMET02601 0.101 0.053 DBMET02600 | DBMET00806 | |
| 0.169 | 0.036 | 0.174 | Platelet activating factor antagonist | 0.168 0.036 DBMET00291 0.143 0.049 DBMET00710 0.104 0.075 DBMET00681 0.174 0.034 DBMET01101 0.174 0.034 DBMET02601 0.174 0.034 DBMET02600 | DBMET02600 | |
| 0.181 | 0.051 | 0.181 | Cyclin-dependent kinase 8 inhibitor | 0.14 0.09 DBMET00710 0.139 0.091 DBMET00681 0.144 0.085 DBMET01101 0.148 0.081 DBMET00684 0.144 0.085 DBMET02601 0.144 0.085 DBMET02600 | ||
| 0.2 | 0.076 | 0.4 | Neurotrophic factor enhancer | 0.152 0.135 DBMET00291 0.234 0.049 DBMET00710 0.195 0.081 DBMET00806 0.26 0.033 DBMET00681 0.244 0.042 DBMET01101 0.4 0.005 DBMET00684 0.244 0.042 DBMET02601 0.244 0.042 DBMET02600 | DBMET00684 | |
| 0.171 | 0.048 | 0.209 | Mannose-6-phosphate isomerase inhibitor | 0.114 0.111 DBMET00291 0.159 0.057 DBMET00710 0.172 0.047 DBMET00806 0.159 0.057 DBMET00681 0.19 0.036 DBMET01101 0.209 0.026 DBMET00684 0.19 0.036 DBMET02601 0.19 0.036 DBMET02600 | DBMET00684 | |
| 0.209 | 0.087 | 0.445 | Cyclic AMP phosphodiesterase inhibitor | 0.153 0.148 DBMET00291 0.204 0.091 DBMET00710 0.211 0.086 DBMET00806 0.234 0.072 DBMET00681 0.245 0.066 DBMET01101 0.445 0.011 DBMET00684 0.245 0.066 DBMET02601 0.245 0.066 DBMET02600 | DBMET00684 | |
| 0.167 | 0.048 | 0.167 | Histone deacetylase SIRT1 inhibitor | 0.153 0.059 DBMET00710 0.156 0.056 DBMET00681 0.149 0.062 DBMET01101 0.154 0.058 DBMET00684 0.149 0.062 DBMET02601 0.149 0.062 DBMET02600 | ||
| 0.237 | 0.119 | 0.455 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.246 0.11 DBMET00710 0.207 0.149 DBMET00681 0.276 0.083 DBMET01101 0.455 0.012 DBMET00684 0.276 0.083 DBMET02601 0.276 0.083 DBMET02600 | DBMET00684 | |
| 0.123 | 0.004 | 0.123 | Glutamate (mGluR7) antagonist | 0.103 0.009 DBMET00291 0.117 0.005 DBMET00804 0.11 0.006 DBMET00710 0.081 0.026 DBMET00806 0.118 0.005 DBMET00681 0.101 0.01 DBMET01101 0.11 0.006 DBMET00684 0.101 0.01 DBMET02601 0.101 0.01 DBMET02600 | ||
| 0.135 | 0.019 | 0.135 | Glutamate (mGluR7) agonist | 0.104 0.052 DBMET00291 0.09 0.084 DBMET00710 0.096 0.068 DBMET00806 0.09 0.084 DBMET00681 | ||
| 0.141 | 0.026 | 0.258 | Prolactin inhibitor | 0.103 0.052 DBMET00291 0.159 0.019 DBMET00710 0.112 0.045 DBMET00806 0.178 0.013 DBMET00681 0.152 0.021 DBMET01101 0.258 0.004 DBMET00684 0.152 0.021 DBMET02601 0.152 0.021 DBMET02600 | DBMET00684 | |
| 0.127 | 0.012 | 0.177 | Granulocyte macrophage colony stimulating factor agonist | 0.085 0.063 DBMET00291 0.084 0.066 DBMET00804 0.13 0.01 DBMET00710 0.083 0.066 DBMET00806 0.13 0.011 DBMET00681 0.152 0.005 DBMET01101 0.177 0.004 DBMET00684 0.152 0.005 DBMET02601 0.152 0.005 DBMET02600 | DBMET00684 | |
| 0.153 | 0.037 | 0.156 | Sphingosine 1-phosphate receptor 2 antagonist | 0.15 0.041 DBMET00710 0.143 0.051 DBMET00681 0.151 0.04 DBMET01101 0.156 0.034 DBMET00684 0.151 0.04 DBMET02601 0.151 0.04 DBMET02600 | DBMET00684 | |
| 0.121 | 0.006 | 0.121 | Phospholipase D inhibitor | 0.096 0.017 DBMET00291 0.09 0.022 DBMET00804 0.088 0.024 DBMET00710 0.097 0.016 DBMET00806 0.09 0.022 DBMET00681 0.082 0.032 DBMET01101 0.113 0.009 DBMET00684 0.082 0.032 DBMET02601 0.082 0.032 DBMET02600 | ||
| 0.172 | 0.059 | 0.232 | Neurotensin receptor agonist | 0.205 0.032 DBMET00710 0.165 0.071 DBMET00806 0.2 0.035 DBMET00681 0.181 0.049 DBMET01101 0.232 0.024 DBMET00684 0.181 0.049 DBMET02601 0.181 0.049 DBMET02600 | DBMET00684 | |
| 0.303 | 0.191 | 0.737 | Caspase 9 stimulant | 0.38 0.124 DBMET00291 0.254 0.248 DBMET00804 0.385 0.12 DBMET00710 0.336 0.157 DBMET00806 0.385 0.12 DBMET00681 0.412 0.104 DBMET01101 0.737 0.019 DBMET00684 0.412 0.104 DBMET02601 0.412 0.104 DBMET02600 | DBMET00684 | |
| 0.2 | 0.088 | 0.324 | Nitric-oxide synthase stimulant | 0.186 0.115 DBMET00291 0.199 0.09 DBMET00710 0.208 0.077 DBMET00806 0.22 0.06 DBMET00681 0.213 0.069 DBMET01101 0.324 0.007 DBMET00684 0.213 0.069 DBMET02601 0.213 0.069 DBMET02600 | DBMET00684 | |
| 0.158 | 0.047 | 0.177 | MAP kinase kinase inhibitor | 0.177 0.038 DBMET00710 0.171 0.04 DBMET00681 0.157 0.048 DBMET01101 0.163 0.045 DBMET00684 0.157 0.048 DBMET02601 0.157 0.048 DBMET02600 | DBMET00710 | |
| 0.117 | 0.006 | 0.117 | Aconitate hydratase inhibitor | 0.066 0.021 DBMET00291 0.062 0.024 DBMET00804 0.078 0.014 DBMET00710 0.072 0.017 DBMET00806 0.078 0.014 DBMET00681 0.076 0.015 DBMET01101 0.082 0.013 DBMET00684 0.076 0.015 DBMET02601 0.076 0.015 DBMET02600 | ||
| 0.14 | 0.029 | 0.201 | HIV-1 integrase (Overall Integration) inhibitor | 0.096 0.059 DBMET00291 0.135 0.031 DBMET00710 0.191 0.014 DBMET00806 0.145 0.027 DBMET00681 0.16 0.022 DBMET01101 0.201 0.011 DBMET00684 0.16 0.022 DBMET02601 0.16 0.022 DBMET02600 | DBMET00684 | |
| 0.195 | 0.085 | 0.294 | MAP kinase kinase 2 inhibitor | 0.183 0.094 DBMET00710 0.18 0.096 DBMET00681 0.18 0.095 DBMET01101 0.294 0.037 DBMET00684 0.18 0.095 DBMET02601 0.18 0.095 DBMET02600 | DBMET00684 | |
| 0.15 | 0.041 | 0.169 | Ca2+-transporting ATPase inhibitor | 0.149 0.045 DBMET00291 0.14 0.072 DBMET00804 0.144 0.061 DBMET00710 0.167 0.015 DBMET00806 0.144 0.061 DBMET00681 0.142 0.066 DBMET01101 0.169 0.014 DBMET00684 0.142 0.066 DBMET02601 0.142 0.066 DBMET02600 | DBMET00684 | |
| 0.139 | 0.033 | 0.255 | UDP-glucose 4-epimerase inhibitor | 0.13 0.037 DBMET00291 0.104 0.057 DBMET00804 0.128 0.038 DBMET00710 0.255 0.013 DBMET00806 0.128 0.038 DBMET00681 0.121 0.043 DBMET01101 0.212 0.017 DBMET00684 0.121 0.043 DBMET02601 0.121 0.043 DBMET02600 | DBMET00806 | |
| 0.123 | 0.017 | 0.309 | Phenylalanine 4-hydroxylase inhibitor | 0.062 0.055 DBMET00291 0.172 0.009 DBMET00710 0.096 0.028 DBMET00806 0.172 0.009 DBMET00681 0.159 0.01 DBMET01101 0.309 0.004 DBMET00684 0.159 0.01 DBMET02601 0.159 0.01 DBMET02600 | DBMET00684 | |
| 0.118 | 0.014 | 0.118 | 5 Hydroxytryptamine 3 antagonist | 0.054 0.043 DBMET00291 | ||
| 0.144 | 0.04 | 0.144 | Aminopeptidase B inhibitor | 0.128 0.048 DBMET00710 0.136 0.044 DBMET00806 0.128 0.048 DBMET00681 0.106 0.061 DBMET01101 0.144 0.04 DBMET00684 0.106 0.061 DBMET02601 0.106 0.061 DBMET02600 | ||
| 0.15 | 0.047 | 0.258 | Aldehyde dehydrogenase inhibitor | 0.221 0.023 DBMET00710 0.151 0.047 DBMET00806 0.216 0.024 DBMET00681 0.156 0.044 DBMET01101 0.258 0.017 DBMET00684 0.156 0.044 DBMET02601 0.156 0.044 DBMET02600 | DBMET00684 | |
| 0.149 | 0.047 | 0.187 | Alkylator | 0.162 0.04 DBMET00291 0.096 0.094 DBMET00804 0.18 0.033 DBMET00710 0.162 0.041 DBMET00806 0.17 0.037 DBMET00681 0.187 0.03 DBMET01101 0.157 0.043 DBMET00684 0.187 0.03 DBMET02601 0.187 0.03 DBMET02600 | DBMET02600 | |
| 0.127 | 0.025 | 0.185 | NADH dehydrogenase inhibitor | 0.114 0.032 DBMET00291 0.095 0.049 DBMET00804 0.115 0.031 DBMET00710 0.185 0.012 DBMET00806 0.124 0.026 DBMET00681 0.116 0.031 DBMET01101 0.167 0.014 DBMET00684 0.116 0.031 DBMET02601 0.116 0.031 DBMET02600 | DBMET00806 | |
| 0.173 | 0.071 | 0.221 | 3C-like protease (Human coronavirus) inhibitor | 0.138 0.124 DBMET00681 0.221 0.041 DBMET00684 | DBMET00684 | |
| 0.236 | 0.136 | 0.357 | Cholesterol antagonist | 0.235 0.136 DBMET00291 0.258 0.119 DBMET00710 0.289 0.098 DBMET00806 0.288 0.099 DBMET00681 0.249 0.126 DBMET01101 0.357 0.061 DBMET00684 0.249 0.126 DBMET02601 0.249 0.126 DBMET02600 | DBMET00684 | |
| 0.171 | 0.071 | 0.283 | Phospholipase C inhibitor | 0.139 0.131 DBMET00291 0.187 0.054 DBMET00710 0.247 0.026 DBMET00806 0.198 0.045 DBMET00681 0.182 0.059 DBMET01101 0.283 0.02 DBMET00684 0.182 0.059 DBMET02601 0.182 0.059 DBMET02600 | DBMET00684 | |
| 0.106 | 0.006 | 0.122 | Cyclin D1 inhibitor | 0.06 0.042 DBMET00291 0.057 0.047 DBMET00804 0.11 0.005 DBMET00710 0.098 0.009 DBMET00681 0.098 0.008 DBMET01101 0.122 0.005 DBMET00684 0.098 0.008 DBMET02601 0.098 0.008 DBMET02600 | DBMET00684 | |
| 0.127 | 0.029 | 0.16 | Triose-phosphate isomerase inhibitor | 0.093 0.056 DBMET00291 0.104 0.044 DBMET00710 0.16 0.017 DBMET00806 0.104 0.044 DBMET00681 0.095 0.054 DBMET01101 0.152 0.019 DBMET00684 0.095 0.054 DBMET02601 0.095 0.054 DBMET02600 | DBMET00806 | |
| 0.113 | 0.015 | 0.122 | Biliverdin reductase inhibitor | 0.068 0.033 DBMET00291 0.064 0.037 DBMET00710 0.122 0.013 DBMET00806 0.064 0.037 DBMET00681 0.064 0.037 DBMET01101 0.078 0.027 DBMET00684 0.064 0.037 DBMET02601 0.064 0.037 DBMET02600 | DBMET00806 | |
| 0.11 | 0.013 | 0.159 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.074 0.023 DBMET00291 0.069 0.026 DBMET00804 0.078 0.021 DBMET00710 0.159 0.008 DBMET00806 0.078 0.021 DBMET00681 0.078 0.021 DBMET01101 0.106 0.013 DBMET00684 0.078 0.021 DBMET02601 0.078 0.021 DBMET02600 | DBMET00806 | |
| 0.185 | 0.089 | 0.329 | Psychostimulant | 0.165 0.104 DBMET00291 0.182 0.091 DBMET00710 0.15 0.116 DBMET00806 0.167 0.102 DBMET00681 0.176 0.095 DBMET01101 0.329 0.036 DBMET00684 0.176 0.095 DBMET02601 0.176 0.095 DBMET02600 | DBMET00684 | |
| 0.158 | 0.063 | 0.251 | CF transmembrane conductance regulator agonist | 0.17 0.046 DBMET00710 0.144 0.087 DBMET00806 0.17 0.046 DBMET00681 0.132 0.114 DBMET01101 0.251 0.006 DBMET00684 0.132 0.114 DBMET02601 0.132 0.114 DBMET02600 | DBMET00684 | |
| 0.105 | 0.011 | 0.129 | Protein kinase C beta inhibitor | 0.074 0.04 DBMET00291 0.1 0.013 DBMET00710 0.082 0.027 DBMET00806 0.104 0.012 DBMET00681 0.096 0.015 DBMET01101 0.129 0.005 DBMET00684 0.096 0.015 DBMET02601 0.096 0.015 DBMET02600 | DBMET00684 | |
| 0.134 | 0.042 | 0.262 | Protein kinase C gamma inhibitor | 0.142 0.036 DBMET00710 0.13 0.045 DBMET00806 0.15 0.031 DBMET00681 0.144 0.035 DBMET01101 0.262 0.005 DBMET00684 0.144 0.035 DBMET02601 0.144 0.035 DBMET02600 | DBMET00684 | |
| 0.182 | 0.09 | 0.312 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.223 0.056 DBMET00710 0.243 0.046 DBMET00806 0.237 0.049 DBMET00681 0.222 0.056 DBMET01101 0.312 0.02 DBMET00684 0.222 0.056 DBMET02601 0.222 0.056 DBMET02600 | DBMET00684 | |
| 0.134 | 0.044 | 0.241 | TRPA1 agonist | 0.135 0.043 DBMET00710 0.156 0.027 DBMET00681 0.125 0.052 DBMET01101 0.241 0.006 DBMET00684 0.125 0.052 DBMET02601 0.125 0.052 DBMET02600 | DBMET00684 | |
| 0.108 | 0.018 | 0.13 | Carbamoyl phosphate synthetase inhibitor | 0.079 0.029 DBMET00291 0.062 0.041 DBMET00804 0.08 0.028 DBMET00710 0.13 0.014 DBMET00806 0.08 0.028 DBMET00681 0.08 0.028 DBMET01101 0.078 0.03 DBMET00684 0.08 0.028 DBMET02601 0.08 0.028 DBMET02600 | DBMET00806 | |
| 0.131 | 0.042 | 0.164 | Transcription factor STAT6 inhibitor | 0.127 0.049 DBMET00710 0.103 0.098 DBMET00806 0.138 0.034 DBMET00681 0.119 0.061 DBMET01101 0.164 0.015 DBMET00684 0.119 0.061 DBMET02601 0.119 0.061 DBMET02600 | DBMET00684 | |
| 0.203 | 0.114 | 0.23 | Neuropeptide Y2 antagonist | 0.184 0.15 DBMET00710 0.194 0.13 DBMET00806 0.193 0.132 DBMET00681 0.23 0.077 DBMET00684 | DBMET00684 | |
| 0.116 | 0.028 | 0.116 | CYP2A6 inhibitor | 0.107 0.032 DBMET00684 | ||
| 0.1 | 0.014 | 0.101 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.073 0.052 DBMET00291 0.069 0.063 DBMET00804 0.072 0.053 DBMET00710 0.101 0.013 DBMET00806 0.077 0.044 DBMET00681 0.074 0.049 DBMET01101 0.091 0.021 DBMET00684 0.074 0.049 DBMET02601 0.074 0.049 DBMET02600 | DBMET00806 | |
| 0.145 | 0.059 | 0.191 | Heat shock protein 70 antagonist | 0.148 0.051 DBMET00710 0.158 0.031 DBMET00806 0.154 0.038 DBMET00681 0.148 0.05 DBMET01101 0.191 0.008 DBMET00684 0.148 0.05 DBMET02601 0.148 0.05 DBMET02600 | DBMET00684 | |
| 0.09 | 0.005 | 0.108 | Ryanodine receptor antagonist | 0.072 0.015 DBMET00291 0.062 0.033 DBMET00804 0.096 0.005 DBMET00710 0.069 0.019 DBMET00806 0.108 0.004 DBMET00681 0.1 0.004 DBMET01101 0.084 0.007 DBMET00684 0.1 0.004 DBMET02601 0.1 0.004 DBMET02600 | DBMET00681 | |
| 0.102 | 0.019 | 0.167 | Argininosuccinate synthase inhibitor | 0.056 0.041 DBMET00291 0.07 0.03 DBMET00710 0.167 0.01 DBMET00806 0.07 0.03 DBMET00681 0.07 0.03 DBMET01101 0.099 0.019 DBMET00684 0.07 0.03 DBMET02601 0.07 0.03 DBMET02600 | DBMET00806 | |
| 0.116 | 0.033 | 0.16 | Histamine N-methyltransferase inhibitor | 0.095 0.051 DBMET00710 0.112 0.036 DBMET00806 0.106 0.04 DBMET00681 0.16 0.011 DBMET00684 | DBMET00684 | |
| 0.111 | 0.028 | 0.286 | Histidine decarboxylase inhibitor | 0.079 0.043 DBMET00291 0.061 0.06 DBMET00804 0.17 0.016 DBMET00710 0.205 0.012 DBMET00806 0.209 0.012 DBMET00681 0.166 0.017 DBMET01101 0.286 0.007 DBMET00684 0.166 0.017 DBMET02601 0.166 0.017 DBMET02600 | DBMET00684 | |
| 0.159 | 0.078 | 0.231 | Heat shock protein 90 alpha antagonist | 0.231 0.034 DBMET00710 0.222 0.038 DBMET00681 0.217 0.04 DBMET01101 0.201 0.048 DBMET00684 0.217 0.04 DBMET02601 0.217 0.04 DBMET02600 | DBMET00710 | |
| 0.117 | 0.037 | 0.198 | Alcohol dehydrogenase inhibitor | 0.157 0.018 DBMET00710 0.173 0.016 DBMET00681 0.145 0.022 DBMET01101 0.198 0.013 DBMET00684 0.145 0.022 DBMET02601 0.145 0.022 DBMET02600 | DBMET00684 | |
| 0.147 | 0.067 | 0.207 | Adenylate cyclase stimulant | 0.133 0.094 DBMET00291 0.155 0.054 DBMET00710 0.174 0.031 DBMET00806 0.166 0.04 DBMET00681 0.168 0.038 DBMET01101 0.207 0.011 DBMET00684 0.168 0.038 DBMET02601 0.168 0.038 DBMET02600 | DBMET00684 | |
| 0.106 | 0.026 | 0.165 | Glutamate decarboxylase inhibitor | 0.069 0.056 DBMET00291 0.149 0.013 DBMET00710 0.113 0.023 DBMET00806 0.132 0.017 DBMET00681 0.141 0.015 DBMET01101 0.165 0.011 DBMET00684 0.141 0.015 DBMET02601 0.141 0.015 DBMET02600 | DBMET00684 | |
| 0.122 | 0.043 | 0.22 | DOPA decarboxylase inhibitor | 0.152 0.02 DBMET00710 0.097 0.083 DBMET00806 0.172 0.012 DBMET00681 0.16 0.017 DBMET01101 0.22 0.005 DBMET00684 0.16 0.017 DBMET02601 0.16 0.017 DBMET02600 | DBMET00684 | |
| 0.28 | 0.202 | 0.306 | MAP kinase 1 inhibitor | 0.268 0.214 DBMET00710 0.248 0.236 DBMET00681 0.306 0.173 DBMET01101 0.274 0.208 DBMET00684 0.306 0.173 DBMET02601 0.306 0.173 DBMET02600 | DBMET02600 | |
| 0.116 | 0.04 | 0.131 | Electrolyte absorption antagonist | 0.095 0.065 DBMET00806 0.131 0.028 DBMET00684 | DBMET00684 | |
| 0.102 | 0.027 | 0.199 | D-Ala-D-Ala ligase inhibitor | 0.08 0.069 DBMET00291 0.122 0.013 DBMET00710 0.087 0.052 DBMET00806 0.133 0.009 DBMET00681 0.123 0.012 DBMET01101 0.199 0.003 DBMET00684 0.123 0.012 DBMET02601 0.123 0.012 DBMET02600 | DBMET00684 | |
| 0.104 | 0.029 | 0.173 | Glycine receptor antagonist | 0.099 0.033 DBMET00291 0.095 0.038 DBMET00804 0.084 0.051 DBMET00710 0.116 0.02 DBMET00806 0.082 0.053 DBMET00681 0.092 0.041 DBMET01101 0.173 0.005 DBMET00684 0.092 0.041 DBMET02601 0.092 0.041 DBMET02600 | DBMET00684 | |
| 0.079 | 0.005 | 0.079 | Vascular adhesion protein 1 inhibitor | 0.047 0.018 DBMET00291 0.036 0.031 DBMET00804 0.036 0.032 DBMET00710 0.038 0.029 DBMET00681 0.036 0.032 DBMET01101 0.036 0.032 DBMET02601 0.036 0.032 DBMET02600 | ||
| 0.096 | 0.023 | 0.096 | Acetylcholine M5 receptor agonist | 0.071 0.043 DBMET00291 0.076 0.038 DBMET00684 | ||
| 0.16 | 0.088 | 0.224 | LIM domain kinase 1 inhibitor | 0.129 0.123 DBMET00710 0.133 0.117 DBMET00681 0.224 0.052 DBMET00684 | DBMET00684 | |
| 0.21 | 0.139 | 0.288 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.288 0.031 DBMET00684 | DBMET00684 | |
| 0.099 | 0.028 | 0.099 | Aminopeptidase I inhibitor | 0.085 0.038 DBMET00710 0.079 0.043 DBMET00806 0.085 0.038 DBMET00681 0.074 0.048 DBMET01101 0.094 0.031 DBMET00684 0.074 0.048 DBMET02601 0.074 0.048 DBMET02600 | ||
| 0.077 | 0.007 | 0.09 | Purinergic P2X4 antagonist | 0.09 0.005 DBMET00710 0.045 0.032 DBMET00806 0.087 0.005 DBMET00681 0.081 0.006 DBMET01101 0.09 0.005 DBMET00684 0.081 0.006 DBMET02601 0.081 0.006 DBMET02600 | DBMET00684 | |
| 0.124 | 0.056 | 0.124 | 5 Hydroxytryptamine 2B antagonist | 0.099 0.085 DBMET00710 0.093 0.091 DBMET00681 0.118 0.063 DBMET00684 | ||
| 0.099 | 0.031 | 0.109 | Glutamate dehydrogenase inhibitor | 0.078 0.047 DBMET00291 0.081 0.044 DBMET00710 0.109 0.026 DBMET00806 0.081 0.044 DBMET00681 0.08 0.045 DBMET01101 0.087 0.038 DBMET00684 0.08 0.045 DBMET02601 0.08 0.045 DBMET02600 | DBMET00806 | |
| 0.179 | 0.115 | 0.563 | Aryl hydrocarbon receptor agonist | 0.179 0.114 DBMET00710 0.188 0.109 DBMET00681 0.182 0.112 DBMET01101 0.563 0.018 DBMET00684 0.182 0.112 DBMET02601 0.182 0.112 DBMET02600 | DBMET00684 | |
| 0.117 | 0.053 | 0.117 | Acetylcholine release stimulant | 0.108 0.07 DBMET00684 | ||
| 0.114 | 0.05 | 0.213 | Xanthine oxidase inhibitor | 0.193 0.021 DBMET00710 0.203 0.019 DBMET00681 0.2 0.019 DBMET01101 0.213 0.017 DBMET00684 0.2 0.019 DBMET02601 0.2 0.019 DBMET02600 | DBMET00684 | |
| 0.12 | 0.057 | 0.249 | Photosensitizer | 0.124 0.053 DBMET00710 0.113 0.067 DBMET00806 0.118 0.06 DBMET00681 0.114 0.065 DBMET01101 0.249 0.006 DBMET00684 0.114 0.065 DBMET02601 0.114 0.065 DBMET02600 | DBMET00684 | |
| 0.089 | 0.027 | 0.158 | MAP kinase kinase 7 inhibitor | 0.107 0.008 DBMET00710 0.085 0.034 DBMET00806 0.113 0.005 DBMET00681 0.099 0.014 DBMET01101 0.158 0.002 DBMET00684 0.099 0.014 DBMET02601 0.099 0.014 DBMET02600 | DBMET00684 | |
| 0.077 | 0.017 | 0.08 | Calcium channel P-type blocker | 0.061 0.053 DBMET00710 0.08 0.014 DBMET00806 0.065 0.038 DBMET00681 0.069 0.029 DBMET00684 | DBMET00806 | |
| 0.12 | 0.062 | 0.271 | Interleukin 8 antagonist | 0.137 0.044 DBMET00710 0.115 0.068 DBMET00806 0.136 0.044 DBMET00681 0.148 0.036 DBMET01101 0.271 0.005 DBMET00684 0.148 0.036 DBMET02601 0.148 0.036 DBMET02600 | DBMET00684 | |
| 0.089 | 0.031 | 0.089 | Calcium channel L-type blocker | |||
| 0.084 | 0.026 | 0.084 | Cannabinoid CB1 receptor agonist | |||
| 0.08 | 0.024 | 0.08 | Glutamate (mGluR6) antagonist | 0.072 0.036 DBMET00291 0.062 0.059 DBMET00804 0.065 0.051 DBMET00710 0.077 0.028 DBMET00806 0.065 0.051 DBMET00681 0.064 0.055 DBMET01101 0.071 0.038 DBMET00684 0.064 0.055 DBMET02601 0.064 0.055 DBMET02600 | ||
| 0.076 | 0.021 | 0.076 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.139 | 0.083 | 0.147 | Neuropeptide Y1 antagonist | 0.135 0.091 DBMET00710 0.144 0.075 DBMET00681 0.147 0.07 DBMET00684 | DBMET00684 | |
| 0.086 | 0.031 | 0.169 | GABA B receptor agonist | 0.1 0.016 DBMET00710 0.077 0.048 DBMET00806 0.097 0.018 DBMET00681 0.095 0.02 DBMET01101 0.169 0.004 DBMET00684 0.095 0.02 DBMET02601 0.095 0.02 DBMET02600 | DBMET00684 | |
| 0.086 | 0.032 | 0.097 | Glycine receptor agonist | 0.082 0.036 DBMET00291 0.067 0.061 DBMET00804 0.076 0.045 DBMET00710 0.097 0.023 DBMET00806 0.076 0.045 DBMET00681 0.074 0.047 DBMET01101 0.086 0.031 DBMET00684 0.074 0.047 DBMET02601 0.074 0.047 DBMET02600 | DBMET00806 | |
| 0.09 | 0.036 | 0.131 | Phosphofructokinase-1 inhibitor | 0.08 0.041 DBMET00291 0.059 0.058 DBMET00804 0.076 0.043 DBMET00710 0.131 0.022 DBMET00806 0.076 0.043 DBMET00681 0.072 0.046 DBMET01101 0.096 0.033 DBMET00684 0.072 0.046 DBMET02601 0.072 0.046 DBMET02600 | DBMET00806 | |
| 0.093 | 0.042 | 0.112 | mTOR complex 2 inhibitor | 0.085 0.058 DBMET00291 0.081 0.065 DBMET00804 0.081 0.065 DBMET00681 0.079 0.072 DBMET01101 0.112 0.022 DBMET00684 0.079 0.072 DBMET02601 0.079 0.072 DBMET02600 | DBMET00684 | |
| 0.077 | 0.025 | 0.099 | 5 Hydroxytryptamine 5A antagonist | 0.061 0.044 DBMET00710 0.063 0.039 DBMET00681 0.058 0.049 DBMET01101 0.099 0.016 DBMET00684 0.058 0.049 DBMET02601 0.058 0.049 DBMET02600 | DBMET00684 | |
| 0.079 | 0.028 | 0.092 | 5 Hydroxytryptamine 3 agonist | 0.06 0.049 DBMET00710 0.058 0.051 DBMET00681 0.092 0.019 DBMET00684 | DBMET00684 | |
| 0.065 | 0.016 | 0.08 | Immunoglobulin Fc receptor antagonist | 0.059 0.026 DBMET00710 0.061 0.022 DBMET00681 0.057 0.032 DBMET01101 0.08 0.006 DBMET00684 0.057 0.032 DBMET02601 0.057 0.032 DBMET02600 | DBMET00684 | |
| 0.096 | 0.046 | 0.103 | Bromodomain-containing protein 2 inhibitor | 0.103 0.037 DBMET00684 | DBMET00684 | |
| 0.14 | 0.091 | 0.217 | Hexokinase inhibitor | 0.168 0.06 DBMET00710 0.168 0.06 DBMET00806 0.16 0.067 DBMET00681 0.154 0.075 DBMET01101 0.217 0.027 DBMET00684 0.154 0.075 DBMET02601 0.154 0.075 DBMET02600 | DBMET00684 | |
| 0.157 | 0.109 | 0.469 | Pyruvate kinase inhibitor | 0.252 0.061 DBMET00710 0.146 0.119 DBMET00806 0.266 0.057 DBMET00681 0.273 0.055 DBMET01101 0.469 0.012 DBMET00684 0.273 0.055 DBMET02601 0.273 0.055 DBMET02600 | DBMET00684 | |
| 0.09 | 0.042 | 0.091 | Catalase inhibitor | 0.065 0.059 DBMET00710 0.065 0.059 DBMET00681 0.091 0.042 DBMET00684 | DBMET00684 | |
| 0.075 | 0.028 | 0.075 | Carbonic anhydrase stimulant | 0.059 0.041 DBMET00684 | ||
| 0.212 | 0.166 | 0.212 | Ca(v)3.3 blocker | |||
| 0.048 | 0.003 | 0.048 | Complement factor D inhibitor | 0.03 0.004 DBMET00291 0.023 0.005 DBMET00804 0.033 0.004 DBMET00710 0.034 0.004 DBMET00681 0.033 0.004 DBMET01101 0.033 0.004 DBMET02601 0.033 0.004 DBMET02600 | ||
| 0.071 | 0.026 | 0.083 | Acyl-CoA dehydrogenase inhibitor | 0.047 0.046 DBMET00291 0.083 0.021 DBMET00806 0.05 0.042 DBMET00684 | DBMET00806 | |
| 0.107 | 0.064 | 0.138 | Falcipain 3 inhibitor | 0.092 0.079 DBMET00806 0.138 0.043 DBMET00684 | DBMET00684 | |
| 0.141 | 0.099 | 0.213 | Arachidonic acid antagonist | 0.145 0.094 DBMET00291 0.125 0.12 DBMET00804 0.142 0.098 DBMET00710 0.187 0.046 DBMET00806 0.166 0.07 DBMET00681 0.161 0.076 DBMET01101 0.213 0.022 DBMET00684 0.161 0.076 DBMET02601 0.161 0.076 DBMET02600 | DBMET00684 | |
| 0.07 | 0.027 | 0.07 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.084 | 0.042 | 0.084 | Histone deacetylase SIRT2 inhibitor | |||
| 0.059 | 0.017 | 0.059 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.068 | 0.026 | 0.115 | GABA receptor antagonist | 0.054 0.038 DBMET00710 0.056 0.036 DBMET00681 0.052 0.042 DBMET01101 0.115 0.013 DBMET00684 0.052 0.042 DBMET02601 0.052 0.042 DBMET02600 | DBMET00684 | |
| 0.116 | 0.074 | 0.116 | Histone deacetylase class III inhibitor | 0.105 0.084 DBMET00710 0.106 0.084 DBMET00681 | ||
| 0.118 | 0.076 | 0.142 | Sphingosine 1-phosphate receptor 4 antagonist | 0.142 0.041 DBMET00684 | DBMET00684 | |
| 0.056 | 0.015 | 0.31 | Kinesin antagonist | 0.31 0.003 DBMET00291 0.046 0.018 DBMET00710 0.059 0.014 DBMET00681 0.035 0.029 DBMET01101 0.095 0.008 DBMET00684 0.035 0.029 DBMET02601 0.035 0.029 DBMET02600 | DBMET00291 | |
| 0.056 | 0.015 | 0.31 | Kinesin-like protein 1 inhibitor | 0.31 0.003 DBMET00291 0.046 0.018 DBMET00710 0.059 0.014 DBMET00681 0.035 0.029 DBMET01101 0.095 0.008 DBMET00684 0.035 0.029 DBMET02601 0.035 0.029 DBMET02600 | DBMET00291 | |
| 0.103 | 0.063 | 0.231 | Carbonic anhydrase XV inhibitor | 0.117 0.049 DBMET00710 0.088 0.087 DBMET00806 0.131 0.039 DBMET00681 0.112 0.053 DBMET01101 0.231 0.014 DBMET00684 0.112 0.053 DBMET02601 0.112 0.053 DBMET02600 | DBMET00684 | |
| 0.068 | 0.028 | 0.089 | 5 Hydroxytryptamine 5 antagonist | 0.053 0.049 DBMET00710 0.055 0.045 DBMET00681 0.089 0.018 DBMET00684 | DBMET00684 | |
| 0.054 | 0.015 | 0.054 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.241 | 0.202 | 0.426 | MAP kinase kinase 6 inhibitor | 0.426 0.044 DBMET00684 | DBMET00684 | |
| 0.156 | 0.12 | 0.357 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.143 0.137 DBMET00710 0.158 0.118 DBMET01101 0.357 0.022 DBMET00684 0.158 0.118 DBMET02601 0.158 0.118 DBMET02600 | DBMET00684 | |
| 0.094 | 0.058 | 0.3 | Protein kinase C zeta inhibitor | 0.116 0.035 DBMET00710 0.099 0.052 DBMET00806 0.124 0.03 DBMET00681 0.119 0.033 DBMET01101 0.3 0.005 DBMET00684 0.119 0.033 DBMET02601 0.119 0.033 DBMET02600 | DBMET00684 | |
| 0.081 | 0.045 | 0.099 | GABA aminotransferase inhibitor | 0.089 0.036 DBMET00710 0.089 0.036 DBMET00681 0.075 0.054 DBMET01101 0.099 0.028 DBMET00684 0.075 0.054 DBMET02601 0.075 0.054 DBMET02600 | DBMET00684 | |
| 0.066 | 0.03 | 0.066 | Phosphodiesterase 1A inhibitor | 0.056 0.052 DBMET00684 | ||
| 0.096 | 0.062 | 0.135 | Lanosterol 14 alpha demethylase inhibitor | 0.098 0.059 DBMET00806 0.135 0.018 DBMET00684 | DBMET00684 | |
| 0.051 | 0.017 | 0.051 | Histamine H1 receptor agonist | 0.047 0.024 DBMET00684 | ||
| 0.062 | 0.029 | 0.109 | GABA A receptor antagonist | 0.048 0.043 DBMET00710 0.05 0.041 DBMET00681 0.109 0.014 DBMET00684 | DBMET00684 | |
| 0.136 | 0.103 | 0.201 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.14 0.093 DBMET00710 0.134 0.107 DBMET00681 0.137 0.101 DBMET01101 0.201 0.018 DBMET00684 0.137 0.101 DBMET02601 0.137 0.101 DBMET02600 | DBMET00684 | |
| 0.07 | 0.038 | 0.08 | MDM2 inhibitor | 0.08 0.02 DBMET00684 | DBMET00684 | |
| 0.108 | 0.076 | 0.108 | Vascular endothelial growth factor antagonist | 0.096 0.086 DBMET01101 0.096 0.086 DBMET02601 0.096 0.086 DBMET02600 | ||
| 0.082 | 0.049 | 0.094 | Interferon agonist | 0.094 0.034 DBMET00806 0.078 0.055 DBMET00684 | DBMET00806 | |
| 0.051 | 0.019 | 0.051 | Glutamate (mGluR group III) antagonist | 0.041 0.036 DBMET00804 0.044 0.029 DBMET00684 | ||
| 0.052 | 0.02 | 0.052 | Histamine H2 receptor agonist | 0.042 0.031 DBMET00684 | ||
| 0.091 | 0.059 | 0.128 | Glutamate release inhibitor | 0.089 0.064 DBMET00291 0.083 0.079 DBMET00710 0.099 0.044 DBMET00806 0.128 0.018 DBMET00684 | DBMET00684 | |
| 0.055 | 0.024 | 0.055 | Oleamide hydrolase inhibitor | 0.043 0.034 DBMET00710 0.045 0.032 DBMET00681 | ||
| 0.071 | 0.04 | 0.071 | Cannabinoid receptor agonist | |||
| 0.055 | 0.024 | 0.055 | Histamine H4 receptor antagonist | |||
| 0.149 | 0.118 | 0.171 | P-glycoprotein inhibitor | 0.153 0.112 DBMET00710 0.171 0.088 DBMET00681 0.164 0.096 DBMET01101 0.164 0.096 DBMET02601 0.164 0.096 DBMET02600 | DBMET00681 | |
| 0.146 | 0.115 | 0.236 | Catenin beta inhibitor | 0.185 0.046 DBMET00710 0.175 0.058 DBMET00681 0.147 0.112 DBMET01101 0.236 0.014 DBMET00684 0.147 0.112 DBMET02601 0.147 0.112 DBMET02600 | DBMET00684 | |
| 0.053 | 0.023 | 0.053 | Cytokine production stimulant | 0.049 0.033 DBMET00806 | ||
| 0.041 | 0.011 | 0.041 | Adenosine uptake inhibitor | 0.033 0.032 DBMET00710 0.036 0.019 DBMET01101 0.036 0.019 DBMET02601 0.036 0.019 DBMET02600 | ||
| 0.128 | 0.098 | 0.221 | MAP3K9 inhibitor | 0.128 0.099 DBMET00710 0.137 0.081 DBMET00681 0.12 0.113 DBMET01101 0.221 0.009 DBMET00684 0.12 0.113 DBMET02601 0.12 0.113 DBMET02600 | DBMET00684 | |
| 0.124 | 0.094 | 0.15 | Cyclooxygenase inhibitor | 0.125 0.093 DBMET00710 0.141 0.078 DBMET00681 0.13 0.087 DBMET01101 0.15 0.07 DBMET00684 0.13 0.087 DBMET02601 0.13 0.087 DBMET02600 | DBMET00684 | |
| 0.068 | 0.038 | 0.075 | Interferon inducer | 0.075 0.029 DBMET00806 0.061 0.05 DBMET00684 | DBMET00806 | |
| 0.105 | 0.076 | 0.105 | Calcium channel (voltage-sensitive) blocker | |||
| 0.059 | 0.03 | 0.112 | NMDA 2A receptor antagonist | 0.075 0.022 DBMET00710 0.054 0.034 DBMET00806 0.089 0.016 DBMET00681 0.053 0.035 DBMET01101 0.112 0.011 DBMET00684 0.053 0.035 DBMET02601 0.053 0.035 DBMET02600 | DBMET00684 | |
| 0.16 | 0.131 | 0.298 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.298 0.04 DBMET00684 | DBMET00684 | |
| 0.07 | 0.042 | 0.07 | Exportin-1 inhibitor | |||
| 0.047 | 0.018 | 0.047 | Kainate receptor agonist | 0.04 0.031 DBMET00291 0.04 0.033 DBMET00710 0.044 0.022 DBMET00806 0.04 0.033 DBMET00681 0.044 0.023 DBMET00684 | ||
| 0.07 | 0.042 | 0.07 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.066 | 0.038 | 0.076 | I kappa B kinase 2 inhibitor | 0.058 0.052 DBMET00710 0.059 0.048 DBMET00681 0.076 0.025 DBMET00684 | DBMET00684 | |
| 0.062 | 0.034 | 0.062 | Cyclin A1 inhibitor | |||
| 0.083 | 0.055 | 0.083 | Caspase 7 inhibitor | 0.083 0.054 DBMET00684 | ||
| 0.095 | 0.068 | 0.095 | Nitric-oxide synthase inhibitor | 0.091 0.075 DBMET00684 | ||
| 0.046 | 0.021 | 0.166 | Dopamine D5 agonist | 0.071 0.008 DBMET00710 0.089 0.005 DBMET00681 0.078 0.006 DBMET01101 0.166 0.002 DBMET00684 0.078 0.006 DBMET02601 0.078 0.006 DBMET02600 | DBMET00684 | |
| 0.045 | 0.019 | 0.074 | AMPA 4 receptor antagonist | 0.038 0.031 DBMET00710 0.038 0.031 DBMET00681 0.074 0.007 DBMET00684 | DBMET00684 | |
| 0.098 | 0.073 | 0.098 | Vascular endothelial growth factor 2 antagonist | 0.085 0.084 DBMET01101 0.085 0.084 DBMET02601 0.085 0.084 DBMET02600 | ||
| 0.087 | 0.063 | 0.096 | Phosphodiesterase I inhibitor | 0.079 0.078 DBMET00681 0.096 0.05 DBMET00684 | DBMET00684 | |
| 0.084 | 0.059 | 0.178 | Myeloperoxidase inhibitor | 0.095 0.042 DBMET00710 0.092 0.046 DBMET00681 0.095 0.042 DBMET01101 0.178 0.007 DBMET00684 0.095 0.042 DBMET02601 0.095 0.042 DBMET02600 | DBMET00684 | |
| 0.038 | 0.013 | 0.049 | Cyclin E2 inhibitor | 0.033 0.016 DBMET00710 0.026 0.023 DBMET00681 0.025 0.023 DBMET01101 0.049 0.009 DBMET00684 0.025 0.023 DBMET02601 0.025 0.023 DBMET02600 | DBMET00684 | |
| 0.092 | 0.069 | 0.092 | Sphingomyelinase inhibitor | 0.086 0.078 DBMET00804 0.091 0.07 DBMET00684 | ||
| 0.049 | 0.027 | 0.049 | Purinergic P2Y antagonist | 0.042 0.034 DBMET00681 | ||
| 0.065 | 0.043 | 0.065 | Protease 3C (Human rhinovirus) inhibitor | 0.065 0.044 DBMET00684 | ||
| 0.049 | 0.028 | 0.049 | Farnesyltransferase inhibitor | |||
| 0.054 | 0.033 | 0.071 | Vanilloid 2 antagonist | 0.059 0.024 DBMET00710 0.06 0.022 DBMET00681 0.071 0.013 DBMET01101 0.071 0.013 DBMET02601 0.071 0.013 DBMET02600 | DBMET02600 | |
| 0.064 | 0.043 | 0.085 | Transcription factor RelA inhibitor | 0.066 0.038 DBMET00710 0.068 0.033 DBMET00681 0.069 0.031 DBMET01101 0.085 0.013 DBMET00684 0.069 0.031 DBMET02601 0.069 0.031 DBMET02600 | DBMET00684 | |
| 0.071 | 0.05 | 0.084 | Benzodiazepine agonist | 0.084 0.036 DBMET00684 | DBMET00684 | |
| 0.041 | 0.02 | 0.041 | Glutamate (mGluR8) agonist | 0.036 0.03 DBMET01101 0.039 0.025 DBMET00684 0.036 0.03 DBMET02601 0.036 0.03 DBMET02600 | ||
| 0.086 | 0.065 | 0.108 | Pim-3 kinase inhibitor | 0.108 0.039 DBMET00684 | DBMET00684 | |
| 0.126 | 0.105 | 0.136 | Thiol protease inhibitor | 0.136 0.086 DBMET00684 | DBMET00684 | |
| 0.057 | 0.037 | 0.104 | 5 Hydroxytryptamine 7 agonist | 0.055 0.04 DBMET00710 0.056 0.039 DBMET00681 0.104 0.006 DBMET00684 | DBMET00684 | |
| 0.03 | 0.01 | 0.03 | Acid ceramidase inhibitor | |||
| 0.11 | 0.09 | 0.229 | Toll-Like receptor 2 antagonist | 0.146 0.056 DBMET00710 0.174 0.037 DBMET00681 0.161 0.045 DBMET01101 0.229 0.013 DBMET00684 0.161 0.045 DBMET02601 0.161 0.045 DBMET02600 | DBMET00684 | |
| 0.043 | 0.024 | 0.056 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.045 0.022 DBMET00710 0.048 0.018 DBMET00806 0.045 0.022 DBMET00681 0.044 0.023 DBMET01101 0.056 0.01 DBMET00684 0.044 0.023 DBMET02601 0.044 0.023 DBMET02600 | DBMET00684 | |
| 0.048 | 0.029 | 0.074 | Adenylate cyclase 1 inhibitor | 0.06 0.018 DBMET00806 0.074 0.01 DBMET00684 | DBMET00684 | |
| 0.045 | 0.026 | 0.095 | GABA B receptor antagonist | 0.095 0.005 DBMET00684 | DBMET00684 | |
| 0.052 | 0.033 | 0.052 | Antiviral (Hepatitis D) | |||
| 0.029 | 0.01 | 0.029 | Complement factor 1s inhibitor | 0.025 0.018 DBMET00684 | ||
| 0.054 | 0.036 | 0.083 | Ornithine carbamoyltransferase inhibitor | 0.083 0.021 DBMET00806 | DBMET00806 | |
| 0.068 | 0.051 | 0.07 | Amidase inhibitor | 0.067 0.053 DBMET00710 0.07 0.048 DBMET00681 0.069 0.05 DBMET01101 0.069 0.05 DBMET02601 0.069 0.05 DBMET02600 | DBMET00681 | |
| 0.119 | 0.101 | 0.162 | Cell wall synthesis inhibitor | 0.162 0.055 DBMET00806 0.119 0.1 DBMET00681 0.114 0.108 DBMET01101 0.144 0.071 DBMET00684 0.114 0.108 DBMET02601 0.114 0.108 DBMET02600 | DBMET00806 | |
| 0.057 | 0.04 | 0.073 | Pregnane X receptor antagonist | 0.053 0.051 DBMET00710 0.057 0.039 DBMET00806 0.054 0.047 DBMET01101 0.073 0.011 DBMET00684 0.054 0.047 DBMET02601 0.054 0.047 DBMET02600 | DBMET00684 | |
| 0.041 | 0.024 | 0.071 | Alpha 1d adrenoreceptor agonist | 0.071 0.007 DBMET00684 | DBMET00684 | |
| 0.112 | 0.096 | 0.112 | Calcium channel blocker | |||
| 0.054 | 0.038 | 0.063 | Epithelial sodium channel blocker | 0.053 0.042 DBMET00710 0.063 0.025 DBMET00684 | DBMET00684 | |
| 0.117 | 0.101 | 0.171 | Nav1.6 sodium channel blocker | 0.171 0.034 DBMET00684 | DBMET00684 | |
| 0.037 | 0.021 | 0.046 | Fumarate hydratase inhibitor | 0.046 0.015 DBMET00806 | DBMET00806 | |
| 0.037 | 0.022 | 0.037 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.032 DBMET00684 | ||
| 0.04 | 0.026 | 0.04 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.142 | 0.129 | 0.243 | I kappa B kinase epsilon inhibitor | 0.137 0.135 DBMET00710 0.243 0.041 DBMET00684 | DBMET00684 | |
| 0.043 | 0.03 | 0.043 | Nerve growth factor antagonist | 0.04 0.036 DBMET00684 | ||
| 0.033 | 0.022 | 0.038 | Protein kinase C beta II inhibitor | 0.033 0.022 DBMET00710 0.034 0.019 DBMET00681 0.038 0.014 DBMET00684 | DBMET00684 | |
| 0.037 | 0.026 | 0.037 | Tryptase inhibitor | |||
| 0.046 | 0.036 | 0.071 | Glucose-6-phosphate isomerase inhibitor | 0.071 0.012 DBMET00806 0.054 0.024 DBMET00684 | DBMET00806 | |
| 0.109 | 0.098 | 0.148 | DNA repair enzyme inhibitor | 0.11 0.095 DBMET00710 0.113 0.088 DBMET00806 0.11 0.096 DBMET01101 0.148 0.033 DBMET00684 0.11 0.096 DBMET02601 0.11 0.096 DBMET02600 | DBMET00684 | |
| 0.089 | 0.079 | 0.167 | Urease inhibitor | 0.098 0.069 DBMET00710 0.108 0.057 DBMET00681 0.1 0.068 DBMET01101 0.167 0.016 DBMET00684 0.1 0.068 DBMET02601 0.1 0.068 DBMET02600 | DBMET00684 | |
| 0.053 | 0.042 | 0.087 | Sphingosine kinase 2 inhibitor | 0.051 0.046 DBMET00710 0.087 0.012 DBMET00806 0.056 0.037 DBMET00681 0.051 0.045 DBMET01101 0.071 0.021 DBMET00684 0.051 0.045 DBMET02601 0.051 0.045 DBMET02600 | DBMET00806 | |
| 0.089 | 0.079 | 0.143 | Anabolic | 0.096 0.068 DBMET00710 0.127 0.033 DBMET00806 0.11 0.049 DBMET00681 0.094 0.072 DBMET01101 0.143 0.022 DBMET00684 0.094 0.072 DBMET02601 0.094 0.072 DBMET02600 | DBMET00684 | |
| 0.023 | 0.014 | 0.023 | Glutamate (mGluR1a) agonist | 0.02 0.018 DBMET00684 | ||
| 0.162 | 0.153 | 0.24 | Spasmolytic | 0.183 0.135 DBMET00710 0.17 0.145 DBMET00806 0.193 0.125 DBMET00681 0.198 0.121 DBMET01101 0.24 0.096 DBMET00684 0.198 0.121 DBMET02601 0.198 0.121 DBMET02600 | DBMET00684 | |
| 0.087 | 0.079 | 0.401 | Carbonic anhydrase III inhibitor | 0.15 0.028 DBMET00710 0.143 0.031 DBMET00681 0.146 0.03 DBMET01101 0.401 0.004 DBMET00684 0.146 0.03 DBMET02601 0.146 0.03 DBMET02600 | DBMET00684 | |
| 0.036 | 0.028 | 0.036 | Factor XIIIa inhibitor | |||
| 0.044 | 0.036 | 0.064 | Adenosine deaminase inhibitor | 0.064 0.017 DBMET00806 0.05 0.031 DBMET00684 | DBMET00806 | |
| 0.075 | 0.068 | 0.098 | I kappa B kinase inhibitor | 0.098 0.04 DBMET00684 | DBMET00684 | |
| 0.068 | 0.061 | 0.079 | Adenosine A3 receptor antagonist | 0.079 0.045 DBMET00684 | DBMET00684 | |
| 0.046 | 0.039 | 0.068 | Dopamine beta hydroxylase inhibitor | 0.048 0.034 DBMET00710 0.048 0.034 DBMET00681 0.068 0.009 DBMET00684 | DBMET00684 | |
| 0.066 | 0.059 | 0.066 | Cathepsin G inhibitor | 0.064 0.062 DBMET00684 | ||
| 0.037 | 0.03 | 0.037 | GABA uptake inhibitor | |||
| 0.028 | 0.021 | 0.032 | Purinergic P2Y15 antagonist | 0.032 0.014 DBMET00806 | DBMET00806 | |
| 0.076 | 0.069 | 0.084 | Inducible nitric-oxide synthase inhibitor | 0.084 0.055 DBMET00684 | DBMET00684 | |
| 0.051 | 0.044 | 0.051 | CC chemokine 2 receptor antagonist | |||
| 0.07 | 0.064 | 0.072 | Vanilloid 4 agonist | 0.072 0.058 DBMET00806 0.07 0.063 DBMET00684 | DBMET00806 | |
| 0.037 | 0.032 | 0.044 | 5 Hydroxytryptamine 2B agonist | 0.044 0.019 DBMET00684 | DBMET00684 | |
| 0.077 | 0.072 | 0.077 | Histamine H2 receptor antagonist | |||
| 0.03 | 0.025 | 0.058 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.051 0.011 DBMET00710 0.058 0.009 DBMET00681 0.041 0.015 DBMET01101 0.032 0.023 DBMET00684 0.041 0.015 DBMET02601 0.041 0.015 DBMET02600 | DBMET00681 | |
| 0.045 | 0.04 | 0.055 | Benzodiazepine antagonist | 0.055 0.019 DBMET00684 | DBMET00684 | |
| 0.034 | 0.031 | 0.034 | Diamine oxidase inhibitor | |||
| 0.02 | 0.018 | 0.02 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.034 | 0.032 | 0.035 | Delayed rectifier potassium channel blocker | 0.035 0.031 DBMET00684 | DBMET00684 | |
| 0.03 | 0.028 | 0.03 | Vanilloid 4 antagonist | |||
| 0.023 | 0.021 | 0.023 | 5 Hydroxytryptamine 4 agonist | |||
| 0.033 | 0.032 | 0.033 | Glutamate (mGluR3) antagonist | 0.033 0.031 DBMET00684 | ||
| 0.042 | 0.041 | 0.09 | AMPA receptor antagonist | 0.09 0.014 DBMET00684 | DBMET00684 | |
| 0.047 | 0.045 | 0.047 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.032 | 0.031 | 0.032 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.101 | 0.101 | 0.167 | Cyclooxygenase 3 inhibitor | 0.115 0.084 DBMET00710 0.108 0.092 DBMET00806 0.13 0.067 DBMET00681 0.114 0.084 DBMET01101 0.167 0.035 DBMET00684 0.114 0.084 DBMET02601 0.114 0.084 DBMET02600 | DBMET00684 | |
| 0.071 | 0.072 | 0.079 | 5 Hydroxytryptamine 2C antagonist | 0.079 0.062 DBMET00684 | DBMET00684 | |
| 0.122 | 0.123 | 0.156 | Pregnane X receptor agonist | 0.124 0.118 DBMET00291 0.125 0.114 DBMET00806 0.156 0.044 DBMET00684 | DBMET00684 | |
| 0.024 | 0.025 | 0.026 | Thymidine phosphorylase inhibitor | 0.026 0.019 DBMET00806 0.024 0.023 DBMET00684 | DBMET00806 | |
| 0.206 | 0.207 | 0.524 | 15-Lipoxygenase inhibitor | 0.298 0.133 DBMET00710 0.338 0.106 DBMET00681 0.327 0.113 DBMET01101 0.524 0.036 DBMET00684 0.327 0.113 DBMET02601 0.327 0.113 DBMET02600 | DBMET00684 | |
| 0.052 | 0.055 | 0.101 | NMDA receptor glycine site agonist | 0.101 0.016 DBMET00684 | DBMET00684 | |
| 0.024 | 0.026 | 0.045 | AMPA 3 receptor antagonist | 0.045 0.011 DBMET00684 | DBMET00684 | |
| 0.06 | 0.063 | 0.168 | NMDA 2 receptor antagonist | 0.11 0.027 DBMET00710 0.136 0.02 DBMET00806 0.109 0.028 DBMET00681 0.079 0.044 DBMET01101 0.168 0.013 DBMET00684 0.079 0.044 DBMET02601 0.079 0.044 DBMET02600 | DBMET00684 | |
| 0.033 | 0.037 | 0.064 | Kainate receptor antagonist | 0.064 0.014 DBMET00684 | DBMET00684 | |
| 0.057 | 0.061 | 0.062 | Histone deacetylase SIRT3 inhibitor | 0.062 0.043 DBMET00684 | DBMET00684 | |
| 0.108 | 0.113 | 0.168 | Activin receptor-like kinase 2 inhibitor | 0.168 0.054 DBMET00684 | DBMET00684 | |
| 0.028 | 0.033 | 0.061 | Kainate receptor 2 antagonist | 0.061 0.011 DBMET00684 | DBMET00684 | |
| 0.025 | 0.03 | 0.034 | Nicotinic alpha3beta4 receptor agonist | 0.034 0.015 DBMET00684 | DBMET00684 | |
| 0.055 | 0.061 | 0.106 | Sphingosine 1-phosphate receptor 4 agonist | 0.106 0.022 DBMET00684 | DBMET00684 | |
| 0.09 | 0.096 | 0.11 | Factor V inhibitor | 0.11 0.051 DBMET00806 | DBMET00806 | |
| 0.076 | 0.082 | 0.127 | Estrogen-related receptor beta agonist | 0.093 0.035 DBMET00710 0.085 0.053 DBMET00806 0.098 0.027 DBMET00681 0.08 0.066 DBMET01101 0.127 0.007 DBMET00684 0.08 0.066 DBMET02601 0.08 0.066 DBMET02600 | DBMET00684 | |
| 0.025 | 0.031 | 0.028 | 5 Hydroxytryptamine 6 agonist | 0.028 0.021 DBMET00684 | DBMET00684 | |
| 0.051 | 0.058 | 0.113 | 5 Hydroxytryptamine 2A agonist | 0.113 0.01 DBMET00684 | DBMET00684 | |
| 0.02 | 0.029 | 0.05 | Uridine phosphorylase inhibitor | 0.05 0.008 DBMET00806 0.028 0.02 DBMET00684 | DBMET00806 | |
| 0.016 | 0.026 | 0.018 | Granulocyte colony stimulating factor receptor agonist | 0.018 0.015 DBMET00684 | DBMET00684 | |
| 0.034 | 0.044 | 0.056 | Guanylate cyclase inhibitor | 0.056 0.015 DBMET00806 0.042 0.031 DBMET00684 | DBMET00806 | |
| 0.052 | 0.062 | 0.091 | NMDA receptor agonist | 0.091 0.023 DBMET00684 | DBMET00684 | |
| 0.032 | 0.043 | 0.048 | Oxytocin agonist | 0.039 0.033 DBMET00710 0.039 0.032 DBMET00681 0.048 0.025 DBMET00684 | DBMET00684 | |
| 0.114 | 0.126 | 0.188 | Heat shock protein 90 antagonist | 0.182 0.048 DBMET00710 0.173 0.054 DBMET00681 0.177 0.051 DBMET01101 0.188 0.044 DBMET00684 0.177 0.051 DBMET02601 0.177 0.051 DBMET02600 | DBMET00684 | |
| 0.114 | 0.126 | 0.138 | Phospholipase A2 inhibitor | 0.133 0.095 DBMET00710 0.138 0.089 DBMET00681 0.13 0.1 DBMET01101 0.137 0.09 DBMET00684 0.13 0.1 DBMET02601 0.13 0.1 DBMET02600 | DBMET00681 | |
| 0.027 | 0.039 | 0.032 | Glutamate (mGluR3) agonist | 0.032 0.024 DBMET00684 | DBMET00684 | |
| 0.184 | 0.197 | 0.29 | Vasodilator, coronary | 0.2 0.182 DBMET00291 0.242 0.142 DBMET00806 0.29 0.096 DBMET00684 | DBMET00684 | |
| 0.048 | 0.061 | 0.054 | Sphingosine 1-phosphate receptor 3 antagonist | 0.053 0.05 DBMET00710 0.054 0.048 DBMET00684 | DBMET00684 | |
| 0.041 | 0.055 | 0.093 | Carbonic anhydrase VB inhibitor | 0.048 0.046 DBMET00681 0.093 0.018 DBMET00684 | DBMET00684 | |
| 0.015 | 0.03 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.015 DBMET00806 | DBMET00806 | |
| 0.064 | 0.079 | 0.14 | Keratolytic | 0.082 0.046 DBMET00710 0.088 0.039 DBMET00806 0.09 0.038 DBMET00681 0.077 0.052 DBMET01101 0.14 0.016 DBMET00684 0.077 0.052 DBMET02601 0.077 0.052 DBMET02600 | DBMET00684 | |
| 0.049 | 0.064 | 0.055 | Phosphodiesterase 1B inhibitor | 0.055 0.05 DBMET00684 | DBMET00684 | |
| 0.046 | 0.062 | 0.092 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.066 0.034 DBMET00710 0.081 0.024 DBMET00681 0.065 0.034 DBMET01101 0.092 0.019 DBMET00684 0.065 0.034 DBMET02601 0.065 0.034 DBMET02600 | DBMET00684 | |
| 0.011 | 0.027 | 0.029 | Alpha 2a adrenoreceptor agonist | 0.029 0.005 DBMET00684 | DBMET00684 | |
| 0.008 | 0.024 | 0.011 | Melatonin 2 antagonist | 0.011 0.01 DBMET00684 | DBMET00684 | |
| 0.084 | 0.1 | 0.267 | Beta glucuronidase inhibitor | 0.121 0.045 DBMET00710 0.12 0.046 DBMET00806 0.123 0.043 DBMET00681 0.121 0.045 DBMET01101 0.267 0.008 DBMET00684 0.121 0.045 DBMET02601 0.121 0.045 DBMET02600 | DBMET00684 | |
| 0.016 | 0.033 | 0.02 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 DBMET00806 | DBMET00806 | |
| 0.007 | 0.024 | 0.01 | Imidazoline I2 receptor antagonist | 0.01 0.009 DBMET00684 | DBMET00684 | |
| 0.012 | 0.029 | 0.016 | Telomerase stimulant | 0.016 0.015 DBMET00806 | DBMET00806 | |
| 0.022 | 0.04 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 DBMET00806 0.029 0.014 DBMET00684 | DBMET00684 | |
| 0.014 | 0.032 | 0.033 | Imidazoline I1 receptor antagonist | 0.033 0.006 DBMET00684 | DBMET00684 | |
| 0.027 | 0.046 | 0.044 | Protein kinase (CK2) beta inhibitor | 0.044 0.009 DBMET00684 | DBMET00684 | |
| 0.062 | 0.08 | 0.096 | Somatostatin 1 agonist | 0.081 0.05 DBMET00710 0.081 0.05 DBMET00681 0.096 0.036 DBMET00684 | DBMET00684 | |
| 0.119 | 0.138 | 0.136 | MAP kinase 3 inhibitor | 0.136 0.094 DBMET00684 | DBMET00684 | |
| 0.023 | 0.043 | 0.041 | Estrogen-related receptor gamma antagonist | 0.029 0.019 DBMET00710 0.027 0.024 DBMET00806 0.029 0.019 DBMET00681 0.041 0.005 DBMET00684 | DBMET00684 | |
| 0.034 | 0.055 | 0.062 | Fructose-1,6-bisphosphatase inhibitor | 0.062 0.016 DBMET00684 | DBMET00684 | |
| 0.016 | 0.037 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.01 DBMET00806 0.025 0.008 DBMET00684 | DBMET00684 | |
| 0.106 | 0.127 | 0.158 | Vanilloid 1 agonist | 0.112 0.108 DBMET00710 0.117 0.095 DBMET00681 0.116 0.097 DBMET01101 0.158 0.031 DBMET00684 0.116 0.097 DBMET02601 0.116 0.097 DBMET02600 | DBMET00684 | |
| 0.032 | 0.053 | 0.054 | Thymidine kinase inhibitor | 0.054 0.016 DBMET00806 0.043 0.026 DBMET00684 | DBMET00806 | |
| 0.07 | 0.092 | 0.277 | MAO A inhibitor | 0.109 0.058 DBMET00710 0.122 0.051 DBMET00681 0.106 0.06 DBMET01101 0.277 0.017 DBMET00684 0.106 0.06 DBMET02601 0.106 0.06 DBMET02600 | DBMET00684 | |
| 0.073 | 0.095 | 0.141 | CC chemokine 5 receptor agonist | 0.084 0.051 DBMET00681 0.141 0.004 DBMET00684 | DBMET00684 | |
| 0.014 | 0.035 | 0.019 | Alpha 2b adrenoreceptor agonist | 0.019 0.012 DBMET00684 | DBMET00684 | |
| 0.054 | 0.078 | 0.097 | Na+ K+ transporting ATPase inhibitor | 0.085 0.045 DBMET00806 0.097 0.034 DBMET00684 | DBMET00684 | |
| 0.011 | 0.035 | 0.028 | Nicotinic acid receptor 1 antagonist | 0.016 0.015 DBMET00681 0.028 0.004 DBMET00684 | DBMET00684 | |
| 0.063 | 0.087 | 0.311 | Carbonic anhydrase VI inhibitor | 0.079 0.058 DBMET00710 0.092 0.045 DBMET00681 0.079 0.058 DBMET01101 0.311 0.006 DBMET00684 0.079 0.058 DBMET02601 0.079 0.058 DBMET02600 | DBMET00684 | |
| 0.039 | 0.063 | 0.141 | Topoisomerase II beta inhibitor | 0.05 0.033 DBMET00681 0.047 0.038 DBMET01101 0.141 0.005 DBMET00684 0.047 0.038 DBMET02601 0.047 0.038 DBMET02600 | DBMET00684 | |
| 0.045 | 0.069 | 0.07 | Dihydroorotate oxidase inhibitor | 0.07 0.017 DBMET00684 | DBMET00684 | |
| 0.019 | 0.043 | 0.024 | Vanilloid 2 agonist | 0.024 0.019 DBMET00806 | DBMET00806 | |
| 0.039 | 0.063 | 0.053 | Bombesin 2 receptor antagonist | 0.053 0.03 DBMET00684 | DBMET00684 | |
| 0.084 | 0.109 | 0.226 | MAO inhibitor | 0.121 0.074 DBMET00710 0.139 0.066 DBMET00681 0.112 0.08 DBMET01101 0.226 0.034 DBMET00684 0.112 0.08 DBMET02601 0.112 0.08 DBMET02600 | DBMET00684 | |
| 0.065 | 0.09 | 0.138 | MAO B inhibitor | 0.092 0.064 DBMET00710 0.11 0.055 DBMET00681 0.083 0.072 DBMET01101 0.138 0.042 DBMET00684 0.083 0.072 DBMET02601 0.083 0.072 DBMET02600 | DBMET00684 | |
| 0.03 | 0.056 | 0.23 | NMDA receptor subunit 3B antagonist | 0.051 0.024 DBMET00710 0.05 0.025 DBMET00681 0.039 0.036 DBMET01101 0.23 0.004 DBMET00684 0.039 0.036 DBMET02601 0.039 0.036 DBMET02600 | DBMET00684 | |
| 0.043 | 0.069 | 0.092 | Fatty acid synthase inhibitor | 0.052 0.048 DBMET00681 0.054 0.044 DBMET01101 0.092 0.013 DBMET00684 0.054 0.044 DBMET02601 0.054 0.044 DBMET02600 | DBMET00684 | |
| 0.018 | 0.044 | 0.026 | CC chemokine 8 receptor antagonist | 0.026 0.011 DBMET00291 | DBMET00291 | |
| 0.008 | 0.035 | 0.027 | Kainate receptor 1 antagonist | 0.027 0.011 DBMET00684 | DBMET00684 | |
| 0.041 | 0.067 | 0.073 | Alpha-mannosidase inhibitor | 0.073 0.015 DBMET00806 0.054 0.035 DBMET00684 | DBMET00806 | |
| 0.018 | 0.045 | 0.03 | Nicotinic acid receptor 2 antagonist | 0.03 0.012 DBMET00684 | DBMET00684 | |
| 0.041 | 0.067 | 0.082 | CD45 antagonist | 0.048 0.039 DBMET00681 0.046 0.044 DBMET01101 0.082 0.012 DBMET00684 0.046 0.044 DBMET02601 0.046 0.044 DBMET02600 | DBMET00684 | |
| 0.022 | 0.049 | 0.043 | Phosphoglycerate kinase inhibitor | 0.043 0.017 DBMET00806 0.032 0.029 DBMET00684 | DBMET00806 | |
| 0.05 | 0.077 | 0.082 | CDC7 inhibitor | 0.082 0.034 DBMET00684 | DBMET00684 | |
| 0.047 | 0.074 | 0.076 | Sphingosine kinase inhibitor | 0.076 0.019 DBMET00806 0.071 0.024 DBMET00684 | DBMET00806 | |
| 0.028 | 0.056 | 0.044 | Glutamate (mGluR1a) antagonist | 0.044 0.026 DBMET00684 | DBMET00684 | |
| 0.132 | 0.16 | 0.195 | Focal adhesion kinase 2 inhibitor | 0.195 0.073 DBMET00684 | DBMET00684 | |
| 0.055 | 0.083 | 0.215 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.107 0.034 DBMET00710 0.097 0.039 DBMET00681 0.1 0.038 DBMET01101 0.215 0.008 DBMET00684 0.1 0.038 DBMET02601 0.1 0.038 DBMET02600 | DBMET00684 | |
| 0.029 | 0.057 | 0.067 | Phosphorylase inhibitor | 0.056 0.027 DBMET00806 0.067 0.021 DBMET00684 | DBMET00684 | |
| 0.098 | 0.126 | 0.18 | Protein kinase stimulant | 0.133 0.081 DBMET00710 0.168 0.057 DBMET00806 0.131 0.083 DBMET00681 0.137 0.078 DBMET01101 0.18 0.05 DBMET00684 0.137 0.078 DBMET02601 0.137 0.078 DBMET02600 | DBMET00684 | |
| 0.013 | 0.042 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.01 DBMET00684 | DBMET00684 | |
| 0.047 | 0.075 | 0.099 | Heat shock protein 90 beta antagonist | 0.071 0.027 DBMET00710 0.069 0.029 DBMET00681 0.08 0.02 DBMET01101 0.099 0.011 DBMET00684 0.08 0.02 DBMET02601 0.08 0.02 DBMET02600 | DBMET00684 | |
| 0.026 | 0.055 | 0.036 | Antibiotic Aminoglycoside-like | 0.036 0.026 DBMET00291 0.034 0.029 DBMET00806 | DBMET00291 | |
| 0.028 | 0.057 | 0.036 | MAP3K5 inhibitor | 0.036 0.033 DBMET00684 | DBMET00684 | |
| 0.025 | 0.054 | 0.038 | Melatonin receptor 1A agonist | 0.038 0.016 DBMET00684 | DBMET00684 | |
| 0.043 | 0.073 | 0.063 | 5 Hydroxytryptamine 1D antagonist | 0.063 0.046 DBMET00684 | DBMET00684 | |
| 0.186 | 0.215 | 0.368 | Interleukin 2 agonist | 0.237 0.134 DBMET00710 0.368 0.038 DBMET00806 0.249 0.119 DBMET00681 0.215 0.165 DBMET01101 0.272 0.096 DBMET00684 0.215 0.165 DBMET02601 0.215 0.165 DBMET02600 | DBMET00806 | |
| 0.006 | 0.036 | 0.011 | Egl nine homolog 3 inhibitor | 0.011 0.01 DBMET00684 | DBMET00684 | |
| 0.035 | 0.065 | 0.046 | mTOR inhibitor | 0.046 0.044 DBMET00684 | DBMET00684 | |
| 0.022 | 0.051 | 0.027 | Hedgehog signaling activator | 0.027 0.02 DBMET00806 | DBMET00806 | |
| 0.009 | 0.039 | 0.017 | Thromboxane A2 agonist | 0.017 0.009 DBMET00806 | DBMET00806 | |
| 0.035 | 0.065 | 0.054 | 5 Hydroxytryptamine 2 agonist | 0.054 0.033 DBMET00684 | DBMET00684 | |
| 0.04 | 0.07 | 0.056 | Pim-2 kinase inhibitor | 0.056 0.036 DBMET00684 | DBMET00684 | |
| 0.016 | 0.047 | 0.028 | Nicotinic alpha4beta2 receptor agonist | 0.028 0.02 DBMET00684 | DBMET00684 | |
| 0.076 | 0.108 | 0.157 | Toll-Like receptor 3 antagonist | 0.157 0.013 DBMET00684 | DBMET00684 | |
| 0.01 | 0.042 | 0.03 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.03 0.008 DBMET00684 | DBMET00684 | |
| 0.033 | 0.067 | 0.048 | CF transmembrane conductance regulator antagonist | 0.048 0.011 DBMET00684 | DBMET00684 | |
| 0.029 | 0.063 | 0.039 | Histone deacetylase 9 inhibitor | 0.039 0.028 DBMET00684 | DBMET00684 | |
| 0.042 | 0.077 | 0.09 | Alpha 2 adrenoreceptor agonist | 0.09 0.018 DBMET00684 | DBMET00684 | |
| 0.03 | 0.065 | 0.071 | Mannosidase inhibitor | 0.071 0.011 DBMET00806 0.044 0.033 DBMET00684 | DBMET00806 | |
| 0.08 | 0.115 | 0.133 | Mucolytic | 0.133 0.043 DBMET00806 0.094 0.086 DBMET00681 0.096 0.084 DBMET01101 0.13 0.046 DBMET00684 0.096 0.084 DBMET02601 0.096 0.084 DBMET02600 | DBMET00806 | |
| 0.124 | 0.159 | 0.244 | ATPase inhibitor | 0.14 0.119 DBMET00291 0.143 0.114 DBMET00806 0.136 0.128 DBMET01101 0.244 0.015 DBMET00684 0.136 0.128 DBMET02601 0.136 0.128 DBMET02600 | DBMET00684 | |
| 0.061 | 0.098 | 0.25 | NMDA receptor antagonist | 0.094 0.051 DBMET00710 0.121 0.035 DBMET00806 0.097 0.049 DBMET00681 0.25 0.009 DBMET00684 | DBMET00684 | |
| 0.057 | 0.094 | 0.073 | Acetylcholine nicotinic agonist | 0.073 0.066 DBMET00684 | DBMET00684 | |
| 0.03 | 0.066 | 0.05 | Sphingosine kinase 1 inhibitor | 0.05 0.017 DBMET00806 0.043 0.026 DBMET00684 | DBMET00806 | |
| 0.007 | 0.044 | 0.022 | NMDA receptor phencyclidine site antagonist | 0.022 0.006 DBMET00684 | DBMET00684 | |
| 0.048 | 0.085 | 0.095 | Carbonic anhydrase VA inhibitor | 0.095 0.027 DBMET00684 | DBMET00684 | |
| 0.029 | 0.067 | 0.05 | Geranyltranstransferase inhibitor | 0.05 0.023 DBMET00684 | DBMET00684 | |
| 0.029 | 0.067 | 0.049 | Thymidylate synthase inhibitor | 0.049 0.028 DBMET00684 | DBMET00684 | |
| 0.04 | 0.079 | 0.106 | Androgen agonist | 0.084 0.022 DBMET00806 0.054 0.05 DBMET00681 0.106 0.013 DBMET00684 | DBMET00684 | |
| 0.004 | 0.043 | 0.015 | Progesterone receptor A antagonist | 0.015 0.004 DBMET00684 | DBMET00684 | |
| 0.087 | 0.127 | 0.167 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.167 0.057 DBMET00684 | DBMET00684 | |
| 0.009 | 0.049 | 0.041 | AMPA 1 receptor antagonist | 0.041 0.014 DBMET00684 | DBMET00684 | |
| 0.075 | 0.115 | 0.174 | Adenylate cyclase inhibitor | 0.144 0.049 DBMET00806 0.098 0.086 DBMET00681 0.098 0.086 DBMET01101 0.174 0.032 DBMET00684 0.098 0.086 DBMET02601 0.098 0.086 DBMET02600 | DBMET00684 | |
| 0.078 | 0.118 | 0.15 | Phosphodiesterase 6D inhibitor | 0.15 0.01 DBMET00684 | DBMET00684 | |
| 0.032 | 0.072 | 0.044 | Potassium channel small-conductance Ca-activated blocker | 0.044 0.032 DBMET00684 | DBMET00684 | |
| 0.066 | 0.106 | 0.17 | Protein kinase C mu inhibitor | 0.081 0.079 DBMET01101 0.17 0.018 DBMET00684 0.081 0.079 DBMET02601 0.081 0.079 DBMET02600 | DBMET00684 | |
| 0.113 | 0.154 | 0.194 | Interferon gamma antagonist | 0.14 0.092 DBMET00291 0.14 0.092 DBMET00710 0.156 0.07 DBMET00806 0.14 0.092 DBMET00681 0.145 0.084 DBMET01101 0.194 0.043 DBMET00684 0.145 0.084 DBMET02601 0.145 0.084 DBMET02600 | DBMET00684 | |
| 0.126 | 0.167 | 0.203 | Insulin sensitizer | 0.147 0.137 DBMET00710 0.185 0.09 DBMET00806 0.151 0.132 DBMET00681 0.149 0.135 DBMET01101 0.203 0.07 DBMET00684 0.149 0.135 DBMET02601 0.149 0.135 DBMET02600 | DBMET00684 | |
| 0.022 | 0.063 | 0.055 | Inosine monophosphate dehydrogenase inhibitor | 0.055 0.012 DBMET00684 | DBMET00684 | |
| 0.022 | 0.063 | 0.069 | Estradiol 17 beta-dehydrogenase inhibitor | 0.05 0.025 DBMET00710 0.069 0.016 DBMET00681 0.047 0.026 DBMET01101 0.062 0.019 DBMET00684 0.047 0.026 DBMET02601 0.047 0.026 DBMET02600 | DBMET00681 | |
| 0.074 | 0.116 | 0.12 | Bile acid receptor antagonist | 0.088 0.079 DBMET00710 0.091 0.071 DBMET00806 0.093 0.065 DBMET00681 0.086 0.083 DBMET01101 0.12 0.019 DBMET00684 0.086 0.083 DBMET02601 0.086 0.083 DBMET02600 | DBMET00684 | |
| 0.039 | 0.081 | 0.125 | NMDA 2C receptor antagonist | 0.125 0.01 DBMET00684 | DBMET00684 | |
| 0.147 | 0.19 | 0.305 | MAP-kinase-activated kinase 5 inhibitor | 0.168 0.151 DBMET00710 0.164 0.158 DBMET00681 0.184 0.125 DBMET01101 0.305 0.027 DBMET00684 0.184 0.125 DBMET02601 0.184 0.125 DBMET02600 | DBMET00684 | |
| 0.031 | 0.074 | 0.111 | Xanthine dehydrogenase inhibitor | 0.076 0.027 DBMET00710 0.071 0.031 DBMET00681 0.08 0.024 DBMET01101 0.111 0.013 DBMET00684 0.08 0.024 DBMET02601 0.08 0.024 DBMET02600 | DBMET00684 | |
| 0.036 | 0.08 | 0.146 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.054 0.036 DBMET00710 0.068 0.023 DBMET00681 0.146 0.005 DBMET00684 | DBMET00684 | |
| 0.062 | 0.106 | 0.093 | Glutathione S-transferase inhibitor | 0.093 0.045 DBMET00684 | DBMET00684 | |
| 0.046 | 0.092 | 0.059 | Leukotriene C antagonist | 0.059 0.031 DBMET00684 | DBMET00684 | |
| 0.078 | 0.124 | 0.329 | Amylase inhibitor | 0.136 0.071 DBMET00710 0.172 0.054 DBMET00806 0.164 0.058 DBMET00681 0.142 0.068 DBMET01101 0.329 0.015 DBMET00684 0.142 0.068 DBMET02601 0.142 0.068 DBMET02600 | DBMET00684 | |
| 0.061 | 0.107 | 0.074 | Neuropeptide Y antagonist | 0.074 0.07 DBMET00684 | DBMET00684 | |
| 0.015 | 0.061 | 0.038 | Sirtuin 2 inhibitor | 0.038 0.019 DBMET00684 | DBMET00684 | |
| 0.046 | 0.092 | 0.085 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.085 0.016 DBMET00684 | DBMET00684 | |
| 0.162 | 0.209 | 0.308 | Transcription factor STAT inhibitor | 0.308 0.051 DBMET00684 | DBMET00684 | |
| 0.035 | 0.083 | 0.132 | Protein kinase C eta inhibitor | 0.048 0.047 DBMET00681 0.132 0.01 DBMET00684 | DBMET00684 | |
| 0.036 | 0.083 | 0.052 | Lysine-specific demethylase 1A inhibitor | 0.052 0.042 DBMET00684 | DBMET00684 | |
| 0.019 | 0.068 | 0.039 | ATP citrate lysase inhibitor | 0.039 0.014 DBMET00684 | DBMET00684 | |
| 0.039 | 0.089 | 0.076 | Botulinum neurotoxin type A inhibitor | 0.076 0.02 DBMET00684 | DBMET00684 | |
| 0.17 | 0.22 | 0.277 | Antithrombotic | 0.215 0.159 DBMET00291 0.277 0.106 DBMET00806 0.257 0.12 DBMET00684 | DBMET00806 | |
| 0.019 | 0.069 | 0.163 | NMDA receptor subunit 3A antagonist | 0.163 0.005 DBMET00684 | DBMET00684 | |
| 0.126 | 0.175 | 0.373 | Death-associated protein kinase 2 inhibitor | 0.141 0.129 DBMET00710 0.152 0.102 DBMET00681 0.163 0.08 DBMET01101 0.373 0.004 DBMET00684 0.163 0.08 DBMET02601 0.163 0.08 DBMET02600 | DBMET00684 | |
| 0.114 | 0.163 | 0.236 | Interleukin 6 antagonist | 0.236 0.026 DBMET00291 0.146 0.095 DBMET00710 0.142 0.102 DBMET00681 0.157 0.079 DBMET01101 0.227 0.029 DBMET00684 0.157 0.079 DBMET02601 0.157 0.079 DBMET02600 | DBMET00291 | |
| 0.04 | 0.09 | 0.093 | Carbonic anhydrase V inhibitor | 0.093 0.03 DBMET00684 | DBMET00684 | |
| 0.053 | 0.105 | 0.087 | Ornithine decarboxylase inhibitor | 0.087 0.059 DBMET00684 | DBMET00684 | |
| 0.016 | 0.067 | 0.048 | Thyroid hormone agonist | 0.024 0.023 DBMET00681 0.048 0.005 DBMET00684 | DBMET00684 | |
| 0.011 | 0.063 | 0.021 | Estrogen-related receptor gamma agonist | 0.021 0.01 DBMET00684 | DBMET00684 | |
| 0.012 | 0.064 | 0.024 | Beta 1 adrenoreceptor agonist | 0.024 0.014 DBMET00684 | DBMET00684 | |
| 0.079 | 0.132 | 0.142 | Microtubule formation inhibitor | 0.11 0.074 DBMET00291 0.126 0.054 DBMET00806 0.142 0.042 DBMET00684 | DBMET00684 | |
| 0.009 | 0.062 | 0.046 | Dopamine autoreceptor agonist | 0.046 0.008 DBMET00684 | DBMET00684 | |
| 0.02 | 0.074 | 0.119 | Somatostatin 5 agonist | 0.119 0.004 DBMET00291 | DBMET00291 | |
| 0.097 | 0.151 | 0.345 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.345 0.027 DBMET00684 | DBMET00684 | |
| 0.04 | 0.094 | 0.06 | 5 Hydroxytryptamine 1B antagonist | 0.06 0.051 DBMET00684 | DBMET00684 | |
| 0.016 | 0.071 | 0.059 | Nicotinic acid receptor agonist | 0.059 0.011 DBMET00684 | DBMET00684 | |
| 0.036 | 0.091 | 0.082 | TRPA1 antagonist | 0.082 0.024 DBMET00684 | DBMET00684 | |
| 0.045 | 0.1 | 0.112 | Aryl hydrocarbon receptor antagonist | 0.112 0.009 DBMET00684 | DBMET00684 | |
| 0.073 | 0.129 | 0.189 | AMP-activated protein kinase stimulant | 0.149 0.029 DBMET00806 0.189 0.013 DBMET00684 | DBMET00684 | |
| 0.027 | 0.083 | 0.053 | Dihydroorotase inhibitor | 0.053 0.021 DBMET00684 | DBMET00684 | |
| 0.03 | 0.087 | 0.047 | Lysophosphatidic acid 3 receptor antagonist | 0.047 0.04 DBMET00684 | DBMET00684 | |
| 0.046 | 0.102 | 0.064 | Protein kinase C alpha inhibitor | 0.064 0.053 DBMET00684 | DBMET00684 | |
| 0.029 | 0.086 | 0.038 | Leukotriene C4 antagonist | 0.038 0.03 DBMET00684 | DBMET00684 | |
| 0.004 | 0.062 | 0.014 | Thrombopoietin agonist | 0.014 0.006 DBMET00684 | DBMET00684 | |
| 0.028 | 0.086 | 0.04 | AICAR transformylase inhibitor | 0.04 0.037 DBMET00684 | DBMET00684 | |
| 0.052 | 0.111 | 0.206 | Macrophage migration inhibitory factor inhibitor | 0.114 0.028 DBMET00710 0.113 0.029 DBMET00681 0.11 0.029 DBMET01101 0.206 0.007 DBMET00684 0.11 0.029 DBMET02601 0.11 0.029 DBMET02600 | DBMET00684 | |
| 0.048 | 0.106 | 0.148 | Beta 3 adrenoreceptor antagonist | 0.062 0.051 DBMET00681 0.148 0.006 DBMET00684 | DBMET00684 | |
| 0.024 | 0.084 | 0.038 | Protein kinase C beta I inhibitor | 0.038 0.012 DBMET00684 | DBMET00684 | |
| 0.009 | 0.069 | 0.043 | NMDA receptor glycine site antagonist | 0.043 0.007 DBMET00684 | DBMET00684 | |
| 0.02 | 0.08 | 0.055 | Dihydropteroate synthase inhibitor | 0.055 0.014 DBMET00684 | DBMET00684 | |
| 0.022 | 0.082 | 0.065 | Growth hormone release inhibitor | 0.065 0.014 DBMET00291 | DBMET00291 | |
| 0.047 | 0.107 | 0.087 | Analgesic, opioid | 0.076 0.052 DBMET00710 0.087 0.04 DBMET00681 0.078 0.05 DBMET00684 | DBMET00681 | |
| 0.107 | 0.167 | 0.23 | Melanin inhibitor | 0.138 0.1 DBMET00710 0.145 0.089 DBMET00806 0.152 0.079 DBMET00681 0.137 0.102 DBMET01101 0.23 0.032 DBMET00684 0.137 0.102 DBMET02601 0.137 0.102 DBMET02600 | DBMET00684 | |
| 0.01 | 0.071 | 0.026 | 5 Hydroxytryptamine 1D agonist | 0.026 0.023 DBMET00684 | DBMET00684 | |
| 0.114 | 0.176 | 0.225 | MAP kinase kinase 4 inhibitor | 0.143 0.077 DBMET00710 0.157 0.049 DBMET00681 0.129 0.118 DBMET01101 0.225 0.008 DBMET00684 0.129 0.118 DBMET02601 0.129 0.118 DBMET02600 | DBMET00684 | |
| 0.077 | 0.139 | 0.112 | Caspase 3 inhibitor | 0.112 0.072 DBMET00684 | DBMET00684 | |
| 0.003 | 0.066 | 0.013 | Thyroid hormone beta agonist | 0.013 0.004 DBMET00684 | DBMET00684 | |
| 0.037 | 0.1 | 0.086 | Bombesin 1 receptor agonist | 0.086 0.023 DBMET00684 | DBMET00684 | |
| 0.149 | 0.213 | 0.283 | Transcription factor STAT3 inhibitor | 0.283 0.062 DBMET00684 | DBMET00684 | |
| 0.1 | 0.165 | 0.165 | Growth hormone agonist | 0.126 0.111 DBMET00710 0.165 0.076 DBMET00806 0.126 0.111 DBMET00681 0.15 0.087 DBMET00684 | DBMET00806 | |
| 0.016 | 0.081 | 0.039 | Carbonic anhydrase IV inhibitor | 0.039 0.034 DBMET00684 | DBMET00684 | |
| 0.161 | 0.226 | 0.434 | Vasodilator, peripheral | 0.403 0.054 DBMET00806 0.434 0.045 DBMET00684 | DBMET00684 | |
| 0.118 | 0.184 | 0.378 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.17 0.121 DBMET01101 0.378 0.043 DBMET00684 0.17 0.121 DBMET02601 0.17 0.121 DBMET02600 | DBMET00684 | |
| 0.108 | 0.174 | 0.224 | Tumour necrosis factor antagonist | 0.224 0.04 DBMET00684 | DBMET00684 | |
| 0.01 | 0.076 | 0.039 | Kainate receptor 4 antagonist | 0.039 0.009 DBMET00684 | DBMET00684 | |
| 0.052 | 0.118 | 0.226 | Potassium channel (Ca-activated) activator | 0.226 0.01 DBMET00684 | DBMET00684 | |
| 0.135 | 0.202 | 0.221 | Calpain inhibitor | 0.221 0.093 DBMET00684 | DBMET00684 | |
| 0.04 | 0.11 | 0.14 | Carbonic anhydrase XIII inhibitor | 0.065 0.063 DBMET00681 0.14 0.024 DBMET00684 | DBMET00684 | |
| 0.008 | 0.078 | 0.023 | Kainate receptor 5 antagonist | 0.023 0.013 DBMET00684 | DBMET00684 | |
| 0.056 | 0.126 | 0.099 | GABA A receptor agonist | 0.099 0.038 DBMET00684 | DBMET00684 | |
| 0.015 | 0.086 | 0.046 | Liver X receptor beta agonist | 0.046 0.012 DBMET00684 | DBMET00684 | |
| 0.071 | 0.143 | 0.143 | Beta amyloid protein antagonist | 0.143 0.046 DBMET00684 | DBMET00684 | |
| 0.046 | 0.119 | 0.059 | Trypsin inhibitor | 0.059 0.051 DBMET00806 | DBMET00806 | |
| 0.044 | 0.117 | 0.081 | Nicotinic alpha4beta2 receptor antagonist | 0.081 0.049 DBMET00684 | DBMET00684 | |
| 0.127 | 0.2 | 0.19 | Histone acetyltransferase inhibitor | 0.19 0.085 DBMET00684 | DBMET00684 | |
| 0.043 | 0.117 | 0.084 | Potassium channel (ATP-sensitive) blocker | 0.084 0.024 DBMET00684 | DBMET00684 | |
| 0.033 | 0.107 | 0.048 | Squalene epoxidase inhibitor | 0.048 0.039 DBMET00684 | DBMET00684 | |
| 0.033 | 0.108 | 0.053 | Beta adrenoreceptor agonist | 0.043 0.039 DBMET00710 0.053 0.013 DBMET00684 | DBMET00684 | |
| 0.064 | 0.14 | 0.205 | Alpha 2b adrenoreceptor antagonist | 0.205 0.022 DBMET00684 | DBMET00684 | |
| 0.105 | 0.181 | 0.242 | DNA methylase inhibitor | 0.154 0.114 DBMET00710 0.141 0.126 DBMET00681 0.198 0.081 DBMET01101 0.242 0.053 DBMET00684 0.198 0.081 DBMET02601 0.198 0.081 DBMET02600 | DBMET00684 | |
| 0.08 | 0.156 | 0.232 | Toll-Like receptor 9 antagonist | 0.232 0.025 DBMET00684 | DBMET00684 | |
| 0.11 | 0.186 | 0.307 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.307 0.041 DBMET00684 | DBMET00684 | |
| 0.027 | 0.104 | 0.052 | Toll-Like receptor 8 antagonist | 0.052 0.039 DBMET00684 | DBMET00684 | |
| 0.033 | 0.111 | 0.051 | Heparanase inhibitor | 0.051 0.043 DBMET00806 0.051 0.041 DBMET00684 | DBMET00684 | |
| 0.015 | 0.093 | 0.044 | Carbonic anhydrase XII inhibitor | 0.044 0.043 DBMET00684 | DBMET00684 | |
| 0.081 | 0.163 | 0.211 | Protein kinase C nu inhibitor | 0.211 0.044 DBMET00684 | DBMET00684 | |
| 0.042 | 0.124 | 0.096 | Histone deacetylase SIRT1 stimulant | 0.071 0.053 DBMET00710 0.067 0.058 DBMET00681 0.096 0.031 DBMET00684 | DBMET00684 | |
| 0.042 | 0.124 | 0.096 | Histone deacetylase stimulant | 0.071 0.053 DBMET00710 0.067 0.058 DBMET00681 0.096 0.031 DBMET00684 | DBMET00684 | |
| 0.027 | 0.11 | 0.094 | Beta 1 adrenoreceptor antagonist | 0.094 0.011 DBMET00684 | DBMET00684 | |
| 0.034 | 0.117 | 0.073 | Nicotinic alpha3beta2 receptor antagonist | 0.073 0.016 DBMET00684 | DBMET00684 | |
| 0.058 | 0.141 | 0.113 | Expectorant | 0.109 0.06 DBMET00806 0.113 0.056 DBMET00684 | DBMET00684 | |
| 0.058 | 0.141 | 0.104 | Uric acid excretion stimulant | 0.093 0.06 DBMET00710 0.095 0.058 DBMET00681 0.104 0.049 DBMET01101 0.087 0.069 DBMET00684 0.104 0.049 DBMET02601 0.104 0.049 DBMET02600 | DBMET02600 | |
| 0.007 | 0.091 | 0.016 | Kainate receptor 3 antagonist | 0.016 0.013 DBMET00684 | DBMET00684 | |
| 0.047 | 0.132 | 0.073 | Beta 2 adrenoreceptor agonist | 0.06 0.052 DBMET00710 0.06 0.049 DBMET00806 0.073 0.015 DBMET00684 | DBMET00684 | |
| 0.02 | 0.107 | 0.067 | CDK5/p25 inhibitor | 0.067 0.012 DBMET00684 | DBMET00684 | |
| 0.02 | 0.107 | 0.057 | Alpha 1d adrenoreceptor antagonist | 0.057 0.043 DBMET00684 | DBMET00684 | |
| 0.059 | 0.147 | 0.161 | Alpha 2c adrenoreceptor antagonist | 0.161 0.028 DBMET00684 | DBMET00684 | |
| 0.014 | 0.103 | 0.048 | Lysophosphatidic acid 2 receptor antagonist | 0.048 0.009 DBMET00684 | DBMET00684 | |
| 0.02 | 0.108 | 0.035 | Benzodiazepine receptor peripheral-type antagonist | 0.035 0.021 DBMET00684 | DBMET00684 | |
| 0.076 | 0.165 | 0.197 | Alkaline phosphatase inhibitor | 0.197 0.034 DBMET00684 | DBMET00684 | |
| 0.008 | 0.097 | 0.022 | Somatostatin 3 antagonist | 0.022 0.013 DBMET00684 | DBMET00684 | |
| 0.015 | 0.104 | 0.037 | Histone deacetylase 8 inhibitor | 0.037 0.033 DBMET00684 | DBMET00684 | |
| 0.079 | 0.17 | 0.119 | Cytidine deaminase inhibitor | 0.119 0.101 DBMET00684 | DBMET00684 | |
| 0.097 | 0.187 | 0.254 | DNA methyltransferase I inhibitor | 0.141 0.114 DBMET00710 0.134 0.124 DBMET00681 0.177 0.082 DBMET01101 0.254 0.045 DBMET00684 0.177 0.082 DBMET02601 0.177 0.082 DBMET02600 | DBMET00684 | |
| 0.021 | 0.112 | 0.068 | Liver X receptor alpha agonist | 0.068 0.009 DBMET00684 | DBMET00684 | |
| 0.084 | 0.175 | 0.134 | Acetylcholine M1 receptor antagonist | 0.134 0.091 DBMET00684 | DBMET00684 | |
| 0.064 | 0.156 | 0.205 | Glycogen synthase kinase-3 alpha inhibitor | 0.205 0.04 DBMET00684 | DBMET00684 | |
| 0.041 | 0.133 | 0.056 | Gonadotropin-releasing hormone receptor agonist | 0.056 0.047 DBMET00684 | DBMET00684 | |
| 0.082 | 0.174 | 0.135 | Antibacterial (Helicobacter pylori) | 0.135 0.062 DBMET00684 | DBMET00684 | |
| 0.028 | 0.121 | 0.084 | Alpha 1b adrenoreceptor antagonist | 0.084 0.043 DBMET00684 | DBMET00684 | |
| 0.019 | 0.112 | 0.044 | Adenosine A2b receptor antagonist | 0.044 0.041 DBMET00684 | DBMET00684 | |
| 0.024 | 0.119 | 0.088 | Beta 2 adrenoreceptor antagonist | 0.088 0.009 DBMET00684 | DBMET00684 | |
| 0.042 | 0.139 | 0.061 | Phosphodiesterase 1C inhibitor | 0.061 0.047 DBMET00684 | DBMET00684 | |
| 0.007 | 0.105 | 0.039 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.039 0.009 DBMET00684 | DBMET00684 | |
| 0.045 | 0.142 | 0.189 | Monophenol monooxygenase inhibitor | 0.103 0.073 DBMET00710 0.12 0.061 DBMET00681 0.097 0.078 DBMET01101 0.189 0.036 DBMET00684 0.097 0.078 DBMET02601 0.097 0.078 DBMET02600 | DBMET00684 | |
| 0.012 | 0.111 | 0.029 | Sodium/glucose cotransporter inhibitor | 0.029 0.012 DBMET00806 0.028 0.014 DBMET00684 | DBMET00806 | |
| 0.018 | 0.117 | 0.046 | RNA-directed RNA polymerase inhibitor | 0.046 0.015 DBMET00684 | DBMET00684 | |
| 0.009 | 0.108 | 0.071 | Progesterone antagonist | 0.071 0.012 DBMET00684 | DBMET00684 | |
| 0.061 | 0.162 | 0.096 | Interleukin 1 beta converting enzyme inhibitor | 0.096 0.062 DBMET00684 | DBMET00684 | |
| 0.028 | 0.13 | 0.056 | Potassium channel (ATP-sensitive) activator | 0.056 0.021 DBMET00684 | DBMET00684 | |
| 0.034 | 0.136 | 0.074 | Glucosylceramidase inhibitor | 0.074 0.019 DBMET00806 0.056 0.036 DBMET00684 | DBMET00806 | |
| 0.044 | 0.146 | 0.148 | Adrenaline agonist | 0.08 0.058 DBMET00710 0.075 0.064 DBMET00681 0.072 0.069 DBMET01101 0.148 0.015 DBMET00684 0.072 0.069 DBMET02601 0.072 0.069 DBMET02600 | DBMET00684 | |
| 0.038 | 0.141 | 0.089 | Platelet growth factor antagonist | 0.071 0.068 DBMET00710 0.089 0.049 DBMET01101 0.083 0.054 DBMET00684 0.089 0.049 DBMET02601 0.089 0.049 DBMET02600 | DBMET02600 | |
| 0.03 | 0.132 | 0.059 | Potassium channel (Inward rectifier) activator | 0.059 0.021 DBMET00684 | DBMET00684 | |
| 0.041 | 0.146 | 0.078 | Alpha adrenoreceptor antagonist | 0.078 0.074 DBMET00684 | DBMET00684 | |
| 0.031 | 0.136 | 0.113 | Alpha adrenoreceptor agonist | 0.113 0.023 DBMET00684 | DBMET00684 | |
| 0.048 | 0.153 | 0.179 | 5-Lipoxygenase inhibitor | 0.111 0.055 DBMET00710 0.137 0.043 DBMET00681 0.151 0.037 DBMET01101 0.179 0.029 DBMET00684 0.151 0.037 DBMET02601 0.151 0.037 DBMET02600 | DBMET00684 | |
| 0.041 | 0.146 | 0.101 | Telomerase inhibitor | 0.101 0.033 DBMET00684 | DBMET00684 | |
| 0.05 | 0.157 | 0.094 | Falcipain 2 inhibitor | 0.094 0.056 DBMET00684 | DBMET00684 | |
| 0.046 | 0.153 | 0.068 | Peroxisome proliferator-activated receptor gamma antagonist | 0.068 0.059 DBMET00684 | DBMET00684 | |
| 0.052 | 0.16 | 0.095 | Falcipain inhibitor | 0.095 0.058 DBMET00684 | DBMET00684 | |
| 0.142 | 0.25 | 0.224 | Calpain 2 inhibitor | 0.224 0.168 DBMET00684 | DBMET00684 | |
| 0.049 | 0.158 | 0.114 | Mediator release inhibitor | 0.114 0.053 DBMET00684 | DBMET00684 | |
| 0.019 | 0.13 | 0.054 | Carbonic anhydrase XIV inhibitor | 0.054 0.029 DBMET00684 | DBMET00684 | |
| 0.047 | 0.158 | 0.133 | Check point kinase 2 inhibitor | 0.133 0.04 DBMET00684 | DBMET00684 | |
| 0.01 | 0.121 | 0.052 | Liver X receptor beta antagonist | 0.052 0.008 DBMET00684 | DBMET00684 | |
| 0.009 | 0.12 | 0.043 | HCV NS5B polymerase inhibitor | 0.043 0.013 DBMET00684 | DBMET00684 | |
| 0.013 | 0.125 | 0.04 | Urokinase inhibitor | 0.04 0.038 DBMET00806 | DBMET00806 | |
| 0.037 | 0.15 | 0.137 | Alpha 2a adrenoreceptor antagonist | 0.137 0.025 DBMET00684 | DBMET00684 | |
| 0.02 | 0.133 | 0.059 | Acid-sensing ion channel blocker | 0.059 0.01 DBMET00684 | DBMET00684 | |
| 0.06 | 0.172 | 0.096 | Proteasome inhibitor | 0.096 0.092 DBMET00684 | DBMET00684 | |
| 0.08 | 0.194 | 0.157 | Diuretic | 0.157 0.071 DBMET00806 0.119 0.106 DBMET00684 | DBMET00806 | |
| 0.087 | 0.202 | 0.293 | NOS3 expression enhancer | 0.141 0.082 DBMET00710 0.17 0.056 DBMET00681 0.154 0.068 DBMET01101 0.293 0.019 DBMET00684 0.154 0.068 DBMET02601 0.154 0.068 DBMET02600 | DBMET00684 | |
| 0.008 | 0.122 | 0.033 | CXC chemokine 2 receptor antagonist | 0.033 0.011 DBMET00684 | DBMET00684 | |
| 0.022 | 0.138 | 0.07 | Alpha 1 adrenoreceptor agonist | 0.07 0.028 DBMET00684 | DBMET00684 | |
| 0.028 | 0.144 | 0.061 | Neuronal nicotinic receptor antagonist | 0.061 0.053 DBMET00684 | DBMET00684 | |
| 0.012 | 0.128 | 0.05 | Carbonic anhydrase VII inhibitor | 0.05 0.028 DBMET00684 | DBMET00684 | |
| 0.046 | 0.164 | 0.068 | Prolactin release inhibitor | 0.068 0.026 DBMET00684 | DBMET00684 | |
| 0.037 | 0.158 | 0.177 | Androgen antagonist | 0.177 0.016 DBMET00684 | DBMET00684 | |
| 0.102 | 0.223 | 0.208 | Lipocortins synthesis antagonist | 0.195 0.06 DBMET00806 0.139 0.123 DBMET00681 0.139 0.123 DBMET01101 0.208 0.052 DBMET00684 0.139 0.123 DBMET02601 0.139 0.123 DBMET02600 | DBMET00684 | |
| 0.017 | 0.139 | 0.054 | Carbonic anhydrase inhibitor | 0.054 0.051 DBMET00684 | DBMET00684 | |
| 0.089 | 0.211 | 0.121 | Hemostatic | 0.121 0.112 DBMET00806 0.12 0.115 DBMET00684 | DBMET00806 | |
| 0.008 | 0.13 | 0.033 | Sodium/glucose cotransporter 2 inhibitor | 0.033 0.011 DBMET00806 | DBMET00806 | |
| 0.131 | 0.254 | 0.359 | Hypoxia-inducible factor 1 alpha inhibitor | 0.187 0.168 DBMET00710 0.207 0.144 DBMET00681 0.198 0.154 DBMET01101 0.359 0.042 DBMET00684 0.198 0.154 DBMET02601 0.198 0.154 DBMET02600 | DBMET00684 | |
| 0.132 | 0.255 | 0.26 | Peptidyltransferase inhibitor | 0.182 0.126 DBMET00710 0.26 0.044 DBMET00806 0.182 0.126 DBMET00681 0.181 0.127 DBMET01101 0.181 0.127 DBMET02601 0.181 0.127 DBMET02600 | DBMET00806 | |
| 0.029 | 0.154 | 0.16 | Dopamine D1 antagonist | 0.16 0.014 DBMET00684 | DBMET00684 | |
| 0.032 | 0.158 | 0.108 | Beta adrenoreceptor antagonist | 0.108 0.014 DBMET00684 | DBMET00684 | |
| 0.033 | 0.159 | 0.081 | Sirtuin 1 inhibitor | 0.081 0.034 DBMET00684 | DBMET00684 | |
| 0.018 | 0.145 | 0.063 | Dihydroorotate dehydrogenase inhibitor | 0.063 0.026 DBMET00684 | DBMET00684 | |
| 0.011 | 0.14 | 0.059 | Vasopressin 2 antagonist | 0.059 0.011 DBMET00806 | DBMET00806 | |
| 0.027 | 0.157 | 0.058 | 5 Hydroxytryptamine 1B agonist | 0.058 0.029 DBMET00684 | DBMET00684 | |
| 0.05 | 0.185 | 0.103 | Cyclin-dependent kinase 9 inhibitor | 0.103 0.059 DBMET00684 | DBMET00684 | |
| 0.078 | 0.214 | 0.159 | Protein kinase (CK1) gamma 3 inhibitor | 0.159 0.079 DBMET00684 | DBMET00684 | |
| 0.048 | 0.184 | 0.154 | Estrogen receptor alpha antagonist | 0.075 0.057 DBMET00710 0.076 0.055 DBMET00681 0.07 0.067 DBMET01101 0.154 0.011 DBMET00684 0.07 0.067 DBMET02601 0.07 0.067 DBMET02600 | DBMET00684 | |
| 0.154 | 0.292 | 0.305 | Antibacterial | 0.305 0.132 DBMET00806 0.304 0.132 DBMET00684 | DBMET00806 | |
| 0.072 | 0.211 | 0.203 | Anticoagulant | 0.203 0.052 DBMET00806 | DBMET00806 | |
| 0.057 | 0.196 | 0.283 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.283 0.03 DBMET00684 | DBMET00684 | |
| 0.037 | 0.177 | 0.113 | Alpha 2 adrenoreceptor antagonist | 0.113 0.039 DBMET00684 | DBMET00684 | |
| 0.02 | 0.16 | 0.057 | Dopamine D3 antagonist | 0.057 0.048 DBMET00684 | DBMET00684 | |
| 0.041 | 0.182 | 0.101 | Phosphodiesterase VI inhibitor | 0.101 0.019 DBMET00684 | DBMET00684 | |
| 0.007 | 0.151 | 0.033 | Glucagon receptor antagonist | 0.033 0.018 DBMET00684 | DBMET00684 | |
| 0.049 | 0.194 | 0.127 | Cholesterol synthesis inhibitor | 0.111 0.074 DBMET00806 0.127 0.059 DBMET00684 | DBMET00684 | |
| 0.035 | 0.181 | 0.132 | Protein kinase (CK2) inhibitor | 0.132 0.041 DBMET00684 | DBMET00684 | |
| 0.045 | 0.19 | 0.151 | Gastric antisecretory | 0.151 0.026 DBMET00806 0.086 0.084 DBMET00684 | DBMET00806 | |
| 0.033 | 0.18 | 0.171 | MAP-kinase-activated kinase 2 inhibitor | 0.171 0.007 DBMET00684 | DBMET00684 | |
| 0.009 | 0.158 | 0.033 | Farnesoid X receptor agonist | 0.033 0.032 DBMET00684 | DBMET00684 | |
| 0.015 | 0.166 | 0.065 | Dopamine D4 antagonist | 0.065 0.039 DBMET00684 | DBMET00684 | |
| 0.065 | 0.216 | 0.225 | Toll-Like receptor antagonist | 0.225 0.022 DBMET00684 | DBMET00684 | |
| 0.04 | 0.191 | 0.186 | MAP-kinase-activated kinase inhibitor | 0.186 0.007 DBMET00684 | DBMET00684 | |
| 0.133 | 0.285 | 0.36 | Alpha-glucosidase inhibitor | 0.229 0.2 DBMET00681 0.36 0.131 DBMET00684 | DBMET00684 | |
| 0.068 | 0.221 | 0.145 | Protein kinase (CK1) gamma 1 inhibitor | 0.145 0.073 DBMET00684 | DBMET00684 | |
| 0.021 | 0.175 | 0.067 | Dopamine antagonist | 0.067 0.057 DBMET00684 | DBMET00684 | |
| 0.038 | 0.192 | 0.139 | Protein kinase (CK2) alpha inhibitor | 0.139 0.048 DBMET00684 | DBMET00684 | |
| 0.013 | 0.173 | 0.088 | Aromatase inhibitor | 0.088 0.024 DBMET00684 | DBMET00684 | |
| 0.047 | 0.208 | 0.369 | Glutamate receptor antagonist | 0.369 0.006 DBMET00804 0.103 0.093 DBMET00806 0.143 0.056 DBMET00684 | DBMET00804 | |
| 0.051 | 0.213 | 0.172 | Cyclooxygenase 1 inhibitor | 0.101 0.099 DBMET00681 0.172 0.047 DBMET00684 | DBMET00684 | |
| 0.042 | 0.207 | 0.172 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.172 0.01 DBMET00684 | DBMET00684 | |
| 0.076 | 0.242 | 0.126 | Sphingosine 1-phosphate receptor 2 agonist | 0.126 0.047 DBMET00684 | DBMET00684 | |
| 0.079 | 0.247 | 0.201 | Hepatoprotectant | 0.201 0.064 DBMET00806 0.152 0.108 DBMET00681 0.159 0.1 DBMET01101 0.143 0.117 DBMET00684 0.159 0.1 DBMET02601 0.159 0.1 DBMET02600 | DBMET00806 | |
| 0.047 | 0.216 | 0.125 | Cyclooxygenase 2 inhibitor | 0.125 0.074 DBMET00684 | DBMET00684 | |
| 0.111 | 0.281 | 0.357 | 12-Lipoxygenase inhibitor | 0.201 0.15 DBMET00681 0.185 0.168 DBMET01101 0.357 0.054 DBMET00684 0.185 0.168 DBMET02601 0.185 0.168 DBMET02600 | DBMET00684 | |
| 0.029 | 0.204 | 0.052 | Factor III inhibitor | 0.052 0.03 DBMET00806 | DBMET00806 | |
| 0.011 | 0.186 | 0.059 | Cyclin E inhibitor | 0.059 0.042 DBMET00684 | DBMET00684 | |
| 0.034 | 0.211 | 0.245 | M18 aspartyl aminopeptidase inhibitor | 0.127 0.065 DBMET00710 0.167 0.044 DBMET00681 0.228 0.026 DBMET01101 0.245 0.022 DBMET00684 0.228 0.026 DBMET02601 0.228 0.026 DBMET02600 | DBMET00684 | |
| 0.073 | 0.251 | 0.294 | Sigma receptor agonist | 0.294 0.04 DBMET00806 0.176 0.071 DBMET00684 | DBMET00806 | |
| 0.051 | 0.231 | 0.128 | Protein kinase (CK1) gamma 2 inhibitor | 0.128 0.06 DBMET00684 | DBMET00684 | |
| 0.046 | 0.227 | 0.104 | MAP kinase 13 inhibitor | 0.104 0.075 DBMET00684 | DBMET00684 | |
| 0.01 | 0.193 | 0.045 | Cyclin E1 inhibitor | 0.045 0.04 DBMET00684 | DBMET00684 | |
| 0.015 | 0.205 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET00684 | DBMET00684 | |
| 0.078 | 0.269 | 0.277 | Death-associated protein kinase 3 inhibitor | 0.277 0.044 DBMET00684 | DBMET00684 | |
| 0.015 | 0.207 | 0.073 | Estrogen-related receptor beta antagonist | 0.039 0.012 DBMET00710 0.046 0.007 DBMET00681 0.03 0.029 DBMET01101 0.073 0.004 DBMET00684 0.03 0.029 DBMET02601 0.03 0.029 DBMET02600 | DBMET00684 | |
| 0.104 | 0.297 | 0.379 | Transcription factor NF kappa B inhibitor | 0.211 0.158 DBMET00806 0.202 0.167 DBMET00681 0.199 0.17 DBMET01101 0.379 0.068 DBMET00684 0.199 0.17 DBMET02601 0.199 0.17 DBMET02600 | DBMET00684 | |
| 0.038 | 0.232 | 0.06 | Heme oxygenase stimulant | 0.06 0.045 DBMET00684 | DBMET00684 | |
| 0.045 | 0.24 | 0.126 | MAP kinase 12 inhibitor | 0.126 0.062 DBMET00684 | DBMET00684 | |
| 0.016 | 0.213 | 0.05 | Neuraminidase (Influenza A) inhibitor | 0.05 0.024 DBMET00806 | DBMET00806 | |
| 0.054 | 0.254 | 0.259 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.259 0.041 DBMET00684 | DBMET00684 | |
| 0.006 | 0.211 | 0.024 | Dopamine D1 agonist | 0.023 0.016 DBMET01101 0.024 0.013 DBMET00684 0.023 0.016 DBMET02601 0.023 0.016 DBMET02600 | DBMET00684 | |
| 0.016 | 0.222 | 0.073 | Prostaglandin-E synthase inhibitor | 0.073 0.045 DBMET00684 | DBMET00684 | |
| 0.024 | 0.234 | 0.047 | Benzodiazepine inverse agonist | 0.047 0.032 DBMET00684 | DBMET00684 | |
| 0.049 | 0.264 | 0.104 | Activin receptor-like kinase 4 inhibitor | 0.104 0.078 DBMET00684 | DBMET00684 | |
| 0.033 | 0.248 | 0.097 | Potassium channel activator | 0.097 0.051 DBMET00684 | DBMET00684 | |
| 0.099 | 0.317 | 0.236 | Cyclin-dependent kinase 3 inhibitor | 0.236 0.019 DBMET00684 | DBMET00684 | |
| 0.032 | 0.252 | 0.144 | Polo-like kinase-4 inhibitor | 0.144 0.04 DBMET00684 | DBMET00684 | |
| 0.08 | 0.303 | 0.144 | Papain-like protease (SARS coronavirus) inhibitor | 0.113 0.101 DBMET00710 0.12 0.081 DBMET00681 0.144 0.04 DBMET00684 | DBMET00684 | |
| 0.037 | 0.264 | 0.085 | Aminoacyl-tRNA synthetase inhibitor | 0.085 0.067 DBMET00684 | DBMET00684 | |
| 0.042 | 0.272 | 0.144 | Protein kinase (CK1) gamma inhibitor | 0.144 0.071 DBMET00684 | DBMET00684 | |
| 0.032 | 0.261 | 0.116 | Protein kinase C delta inhibitor | 0.116 0.039 DBMET00684 | DBMET00684 | |
| 0.024 | 0.256 | 0.099 | Protein kinase A inhibitor | 0.099 0.046 DBMET00684 | DBMET00684 | |
| 0.041 | 0.276 | 0.105 | Thioredoxin inhibitor | 0.105 0.042 DBMET00684 | DBMET00684 | |
| 0.026 | 0.273 | 0.104 | Pim-1 kinase inhibitor | 0.104 0.054 DBMET00684 | DBMET00684 | |
| 0.006 | 0.258 | 0.039 | Dopamine D3 agonist | 0.039 0.028 DBMET00684 | DBMET00684 | |
| 0.024 | 0.276 | 0.05 | Phosphodiesterase 6C inhibitor | 0.05 0.022 DBMET00684 | DBMET00684 | |
| 0.053 | 0.309 | 0.138 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.138 0.106 DBMET00684 | DBMET00684 | |
| 0.017 | 0.276 | 0.186 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.186 0.015 DBMET00684 | DBMET00684 | |
| 0.021 | 0.282 | 0.173 | Cyclin B3 inhibitor | 0.173 0.009 DBMET00684 | DBMET00684 | |
| 0.012 | 0.274 | 0.094 | 5 Hydroxytryptamine 1F antagonist | 0.094 0.034 DBMET00684 | DBMET00684 | |
| 0.049 | 0.316 | 0.128 | CDC-like kinase 3 inhibitor | 0.128 0.034 DBMET00684 | DBMET00684 | |
| 0.036 | 0.304 | 0.15 | CDC-like kinase 2 inhibitor | 0.15 0.093 DBMET00684 | DBMET00684 | |
| 0.06 | 0.333 | 0.28 | Antiamyloidogenic | 0.28 0.059 DBMET00684 | DBMET00684 | |
| 0.037 | 0.311 | 0.122 | Phosphodiesterase 11A inhibitor | 0.122 0.019 DBMET00684 | DBMET00684 | |
| 0.037 | 0.311 | 0.122 | Phosphodiesterase XI inhibitor | 0.122 0.019 DBMET00684 | DBMET00684 | |
| 0.061 | 0.336 | 0.107 | Interleukin 2 antagonist | 0.101 0.088 DBMET00291 0.107 0.071 DBMET00806 | DBMET00806 | |
| 0.037 | 0.313 | 0.254 | Lipid peroxidase inhibitor | 0.15 0.068 DBMET00710 0.184 0.049 DBMET00806 0.165 0.058 DBMET00681 0.187 0.047 DBMET01101 0.254 0.026 DBMET00684 0.187 0.047 DBMET02601 0.187 0.047 DBMET02600 | DBMET00684 | |
| 0.028 | 0.306 | 0.192 | DNA intercalator | 0.192 0.028 DBMET00684 | DBMET00684 | |
| 0.015 | 0.3 | 0.166 | Check point kinase 1 inhibitor | 0.166 0.013 DBMET00684 | DBMET00684 | |
| 0.032 | 0.326 | 0.111 | Acetylcholinesterase inhibitor | 0.111 0.088 DBMET00684 | DBMET00684 | |
| 0.007 | 0.304 | 0.108 | Phosphodiesterase 3B inhibitor | 0.108 0.01 DBMET00684 | DBMET00684 | |
| 0.033 | 0.336 | 0.152 | CDC-like kinase 4 inhibitor | 0.152 0.1 DBMET00684 | DBMET00684 | |
| 0.027 | 0.331 | 0.085 | I kappa B kinase 1 inhibitor | 0.085 0.032 DBMET00684 | DBMET00684 | |
| 0.031 | 0.336 | 0.2 | Antineoplastic alkaloid | 0.075 0.073 DBMET01101 0.2 0.014 DBMET00684 0.075 0.073 DBMET02601 0.075 0.073 DBMET02600 | DBMET00684 | |
| 0.039 | 0.347 | 0.079 | Thioredoxin reductase inhibitor | 0.079 0.065 DBMET00804 | DBMET00804 | |
| 0.02 | 0.33 | 0.046 | Factor IXa inhibitor | 0.046 0.044 DBMET00806 | DBMET00806 | |
| 0.055 | 0.366 | 0.212 | Prostaglandin dehydrogenase inhibitor | 0.212 0.149 DBMET00684 | DBMET00684 | |
| 0.034 | 0.348 | 0.233 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.233 0.029 DBMET00684 | DBMET00684 | |
| 0.011 | 0.329 | 0.05 | Plasminogen activator inhibitor antagonist | 0.05 0.032 DBMET00684 | DBMET00684 | |
| 0.046 | 0.366 | 0.196 | Interleukin 4 antagonist | 0.123 0.081 DBMET00710 0.119 0.087 DBMET00806 0.136 0.064 DBMET00681 0.135 0.066 DBMET01101 0.196 0.023 DBMET00684 0.135 0.066 DBMET02601 0.135 0.066 DBMET02600 | DBMET00684 | |
| 0.038 | 0.365 | 0.082 | Interleukin 5 antagonist | 0.082 0.068 DBMET00684 | DBMET00684 | |
| 0.015 | 0.342 | 0.11 | Phosphodiesterase III inhibitor | 0.11 0.019 DBMET00684 | DBMET00684 | |
| 0.112 | 0.446 | 0.284 | Cyclophilin D inhibitor | 0.284 0.177 DBMET00806 | DBMET00806 | |
| 0.024 | 0.364 | 0.274 | Tubulin antagonist | 0.155 0.056 DBMET01101 0.274 0.022 DBMET00684 0.155 0.056 DBMET02601 0.155 0.056 DBMET02600 | DBMET00684 | |
| 0.025 | 0.366 | 0.12 | Potassium channel large-conductance Ca-activated activator | 0.12 0.016 DBMET00684 | DBMET00684 | |
| 0.034 | 0.38 | 0.251 | EphB2 antagonist | 0.251 0.056 DBMET00684 | DBMET00684 | |
| 0.005 | 0.353 | 0.066 | Dopamine D2 agonist | 0.066 0.019 DBMET00684 | DBMET00684 | |
| 0.034 | 0.385 | 0.113 | Interleukin 1b antagonist | 0.113 0.068 DBMET00684 | DBMET00684 | |
| 0.099 | 0.451 | 0.27 | ErbB-1 antagonist | 0.172 0.13 DBMET00710 0.168 0.137 DBMET01101 0.27 0.043 DBMET00684 0.168 0.137 DBMET02601 0.168 0.137 DBMET02600 | DBMET00684 | |
| 0.009 | 0.364 | 0.094 | Dopamine agonist | 0.094 0.03 DBMET00684 | DBMET00684 | |
| 0.026 | 0.382 | 0.197 | Clk dual-specificity kinase inhibitor | 0.197 0.081 DBMET00684 | DBMET00684 | |
| 0.045 | 0.402 | 0.135 | Interleukin 12 antagonist | 0.093 0.067 DBMET00710 0.135 0.018 DBMET00684 | DBMET00684 | |
| 0.005 | 0.371 | 0.035 | Opioid delta receptor agonist | 0.035 0.024 DBMET00684 | DBMET00684 | |
| 0.005 | 0.378 | 0.643 | Dopamine D5 antagonist | 0.643 0.003 DBMET00806 0.053 0.024 DBMET00684 | DBMET00806 | |
| 0.026 | 0.407 | 0.169 | Thrombolytic | 0.121 0.109 DBMET00806 0.169 0.068 DBMET00684 | DBMET00684 | |
| 0.023 | 0.405 | 0.219 | CDC-like kinase 1 inhibitor | 0.219 0.027 DBMET00684 | DBMET00684 | |
| 0.006 | 0.39 | 0.03 | Melatonin 2 agonist | 0.03 0.027 DBMET00684 | DBMET00684 | |
| 0.005 | 0.389 | 0.048 | Opioid mu receptor agonist | 0.048 0.03 DBMET00684 | DBMET00684 | |
| 0.025 | 0.422 | 0.239 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.239 0.031 DBMET00684 | DBMET00684 | |
| 0.008 | 0.408 | 0.093 | Cyclin B2 inhibitor | 0.093 0.01 DBMET00684 | DBMET00684 | |
| 0.005 | 0.407 | 0.122 | Beta tubulin antagonist | 0.062 0.039 DBMET01101 0.122 0.017 DBMET00684 0.062 0.039 DBMET02601 0.062 0.039 DBMET02600 | DBMET00684 | |
| 0.034 | 0.437 | 0.116 | Nav1.1 sodium channel blocker | 0.116 0.051 DBMET00806 | DBMET00806 | |
| 0.007 | 0.412 | 0.116 | Opioid delta receptor antagonist | 0.116 0.027 DBMET00684 | DBMET00684 | |
| 0.037 | 0.445 | 0.443 | Antimitotic | 0.443 0.018 DBMET00291 0.142 0.13 DBMET00804 0.148 0.123 DBMET01101 0.258 0.057 DBMET00684 0.148 0.123 DBMET02601 0.148 0.123 DBMET02600 | DBMET00291 | |
| 0.022 | 0.431 | 0.449 | Dyrk kinase inhibitor | 0.449 0.019 DBMET00684 | DBMET00684 | |
| 0.021 | 0.433 | 0.472 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.472 0.016 DBMET00684 | DBMET00684 | |
| 0.014 | 0.428 | 0.069 | Toll-Like receptor 7 antagonist | 0.069 0.048 DBMET00684 | DBMET00684 | |
| 0.008 | 0.422 | 0.126 | Alpha tubulin antagonist | 0.061 0.03 DBMET01101 0.126 0.012 DBMET00684 0.061 0.03 DBMET02601 0.061 0.03 DBMET02600 | DBMET00684 | |
| 0.01 | 0.436 | 0.201 | Cyclin-dependent kinase 5 inhibitor | 0.201 0.022 DBMET00684 | DBMET00684 | |
| 0.016 | 0.444 | 0.253 | Topoisomerase I inhibitor | 0.253 0.016 DBMET00684 | DBMET00684 | |
| 0.007 | 0.437 | 0.087 | Cyclin B inhibitor | 0.087 0.013 DBMET00684 | DBMET00684 | |
| 0.031 | 0.463 | 0.09 | Vanilloid agonist | 0.09 0.048 DBMET00684 | DBMET00684 | |
| 0.037 | 0.474 | 0.14 | Aurora-C kinase inhibitor | 0.14 0.065 DBMET00684 | DBMET00684 | |
| 0.064 | 0.503 | 0.166 | Death-associated protein kinase 1 inhibitor | 0.166 0.021 DBMET00684 | DBMET00684 | |
| 0.008 | 0.451 | 0.09 | Cyclin B1 inhibitor | 0.09 0.015 DBMET00684 | DBMET00684 | |
| 0.007 | 0.451 | 0.108 | Opioid mu receptor antagonist | 0.108 0.029 DBMET00684 | DBMET00684 | |
| 0.013 | 0.46 | 0.074 | Phosphodiesterase 3A inhibitor | 0.074 0.066 DBMET00684 | DBMET00684 | |
| 0.007 | 0.454 | 0.047 | Cathepsin L2 inhibitor | 0.047 0.024 DBMET00684 | DBMET00684 | |
| 0.061 | 0.514 | 0.174 | Growth factor agonist | 0.174 0.095 DBMET00684 | DBMET00684 | |
| 0.014 | 0.473 | 0.172 | Antiadrenergic | 0.172 0.03 DBMET00806 | DBMET00806 | |
| 0.014 | 0.474 | 0.162 | Adrenaline antagonist | 0.162 0.032 DBMET00806 | DBMET00806 | |
| 0.014 | 0.475 | 0.184 | Topoisomerase II alpha inhibitor | 0.184 0.017 DBMET00684 | DBMET00684 | |
| 0.016 | 0.484 | 0.057 | CXC chemokine 1 receptor antagonist | 0.057 0.026 DBMET00684 | DBMET00684 | |
| 0.005 | 0.473 | 0.045 | Aldose reductase inhibitor | 0.045 0.044 DBMET00684 | DBMET00684 | |
| 0.007 | 0.476 | 0.033 | Estrogen-related receptor alpha antagonist | 0.033 0.022 DBMET00684 | DBMET00684 | |
| 0.051 | 0.529 | 0.175 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.175 0.101 DBMET00684 | DBMET00684 | |
| 0.024 | 0.503 | 0.226 | Angiogenesis stimulant | 0.179 0.106 DBMET00806 0.226 0.082 DBMET00684 | DBMET00684 | |
| 0.01 | 0.492 | 0.062 | CDK2/cyclin E2 inhibitor | 0.062 0.059 DBMET00684 | DBMET00684 | |
| 0.004 | 0.499 | 0.073 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.032 0.027 DBMET00681 0.073 0.008 DBMET00684 | DBMET00684 | |
| 0.031 | 0.528 | 0.364 | Antioxidant | 0.201 0.113 DBMET00710 0.194 0.118 DBMET00806 0.232 0.094 DBMET00681 0.263 0.077 DBMET01101 0.364 0.043 DBMET00684 0.263 0.077 DBMET02601 0.263 0.077 DBMET02600 | DBMET00684 | |
| 0.019 | 0.526 | 0.105 | Multidrug resistance-associated protein 1 inhibitor | 0.105 0.069 DBMET00684 | DBMET00684 | |
| 0.023 | 0.531 | 0.142 | Dual specificity phosphatase inhibitor | 0.142 0.104 DBMET00684 | DBMET00684 | |
| 0.016 | 0.526 | 0.126 | Opioid antagonist | 0.126 0.034 DBMET00684 | DBMET00684 | |
| 0.024 | 0.537 | 0.094 | Alpha 2d adrenoreceptor antagonist | 0.094 0.062 DBMET00684 | DBMET00684 | |
| 0.01 | 0.525 | 0.307 | Glutamate (mGluR) antagonist | 0.307 0.005 DBMET00804 | DBMET00804 | |
| 0.008 | 0.532 | 0.06 | Neuraminidase (influenza) inhibitor | 0.06 0.054 DBMET00806 | DBMET00806 | |
| 0.025 | 0.56 | 0.137 | Amyloid beta precursor protein antagonist | 0.137 0.116 DBMET00684 | DBMET00684 | |
| 0.002 | 0.545 | 0.092 | Estrogen receptor alpha agonist | 0.032 0.025 DBMET00681 0.092 0.01 DBMET00684 | DBMET00684 | |
| 0.025 | 0.574 | 0.125 | DNA polymerase I inhibitor | 0.125 0.065 DBMET00806 0.11 0.076 DBMET00684 | DBMET00806 | |
| 0.017 | 0.568 | 0.162 | Breast cancer-resistant protein inhibitor | 0.162 0.02 DBMET00684 | DBMET00684 | |
| 0.015 | 0.568 | 0.097 | ATPase (Vacuolar H+) inhibitor | 0.097 0.045 DBMET00804 0.097 0.044 DBMET00684 | DBMET00684 | |
| 0.018 | 0.573 | 0.117 | Opioid kappa receptor antagonist | 0.117 0.025 DBMET00684 | DBMET00684 | |
| 0.005 | 0.562 | 0.127 | Cyclin-dependent kinase 1 inhibitor | 0.127 0.051 DBMET00684 | DBMET00684 | |
| 0.008 | 0.567 | 0.073 | CDC25A inhibitor | 0.073 0.052 DBMET00684 | DBMET00684 | |
| 0.019 | 0.594 | 0.06 | Cathepsin E inhibitor | 0.06 0.04 DBMET00806 | DBMET00806 | |
| 0.023 | 0.598 | 0.109 | Toll-Like receptor 4 antagonist | 0.109 0.056 DBMET00684 | DBMET00684 | |
| 0.005 | 0.587 | 0.083 | HIV-1 integrase (3'-Processing) inhibitor | 0.056 0.052 DBMET01101 0.083 0.032 DBMET00684 0.056 0.052 DBMET02601 0.056 0.052 DBMET02600 | DBMET00684 | |
| 0.005 | 0.59 | 0.032 | Liver X receptor alpha antagonist | 0.032 0.015 DBMET00684 | DBMET00684 | |
| 0.01 | 0.596 | 0.235 | Topoisomerase II inhibitor | 0.235 0.027 DBMET00684 | DBMET00684 | |
| 0.017 | 0.604 | 0.423 | Free radical scavenger | 0.189 0.107 DBMET00710 0.214 0.087 DBMET00681 0.265 0.063 DBMET01101 0.423 0.025 DBMET00684 0.265 0.063 DBMET02601 0.265 0.063 DBMET02600 | DBMET00684 | |
| 0.029 | 0.617 | 0.083 | T cell inhibitor | 0.083 0.056 DBMET00291 0.082 0.06 DBMET00804 | DBMET00291 | |
| 0.005 | 0.6 | 0.109 | HIV-1 integrase (Strand Transfer) inhibitor | 0.109 0.019 DBMET00806 0.062 0.04 DBMET00684 | DBMET00806 | |
| 0.002 | 0.602 | 0.14 | Estrogen receptor beta agonist | 0.14 0.008 DBMET00684 | DBMET00684 | |
| 0.007 | 0.623 | 0.08 | Phosphodiesterase V inhibitor | 0.08 0.041 DBMET00684 | DBMET00684 | |
| 0.007 | 0.628 | 0.073 | Phosphodiesterase 5A inhibitor | 0.073 0.047 DBMET00684 | DBMET00684 | |
| 0.003 | 0.625 | 0.127 | Squalene synthetase inhibitor | 0.127 0.005 DBMET00291 | DBMET00291 | |
| 0.02 | 0.644 | 0.13 | Insulin secretagoues | 0.13 0.097 DBMET00684 | DBMET00684 | |
| 0.013 | 0.649 | 0.126 | Dual specificity phosphatase 3 inhibitor | 0.126 0.121 DBMET00684 | DBMET00684 | |
| 0.004 | 0.646 | 0.03 | Liver X receptor antagonist | 0.03 0.023 DBMET00684 | DBMET00684 | |
| 0.009 | 0.654 | 0.276 | Estrogen receptor beta antagonist | 0.129 0.024 DBMET00710 0.131 0.023 DBMET00681 0.105 0.055 DBMET01101 0.276 0.005 DBMET00684 0.105 0.055 DBMET02601 0.105 0.055 DBMET02600 | DBMET00684 | |
| 0.015 | 0.672 | 0.249 | Streptokinase A inhibitor | 0.249 0.104 DBMET00684 | DBMET00684 | |
| 0.003 | 0.672 | 0.129 | Estrogen agonist | 0.045 0.039 DBMET00681 0.129 0.013 DBMET00684 | DBMET00684 | |
| 0.017 | 0.693 | 0.39 | Amyloid beta aggregation inhibitor | 0.39 0.026 DBMET00684 | DBMET00684 | |
| 0.004 | 0.684 | 0.041 | Catechol O-methyltransferase inhibitor | 0.041 0.013 DBMET01101 0.032 0.024 DBMET00684 0.041 0.013 DBMET02601 0.041 0.013 DBMET02600 | DBMET02600 | |
| 0.016 | 0.697 | 0.16 | Farnesoid X receptor antagonist | 0.16 0.042 DBMET00684 | DBMET00684 | |
| 0.014 | 0.708 | 0.161 | Nitric oxide antagonist | 0.161 0.087 DBMET00684 | DBMET00684 | |
| 0.021 | 0.721 | 0.054 | Lipocortins synthesis agonist | 0.054 0.052 DBMET00806 | DBMET00806 | |
| 0.009 | 0.744 | 0.129 | Chelator | 0.129 0.046 DBMET00684 | DBMET00684 | |
| 0.008 | 0.745 | 0.346 | Platelet antagonist | 0.346 0.039 DBMET00806 | DBMET00806 | |
| 0.009 | 0.75 | 0.292 | Estrogen antagonist | 0.136 0.032 DBMET00710 0.139 0.029 DBMET00681 0.111 0.072 DBMET01101 0.292 0.006 DBMET00684 0.111 0.072 DBMET02601 0.111 0.072 DBMET02600 | DBMET00684 | |
| 0.005 | 0.75 | 0.067 | CDC25B inhibitor | 0.067 0.041 DBMET00684 | DBMET00684 | |
| 0.005 | 0.756 | 0.144 | Mcl-1 antagonist | 0.144 0.096 DBMET00684 | DBMET00684 | |
| 0.005 | 0.757 | 0.132 | Protein-tyrosine phosphatase inhibitor | 0.132 0.099 DBMET00684 | DBMET00684 | |
| 0.004 | 0.76 | 0.092 | Protein-tyrosine phosphatase 1B inhibitor | 0.092 0.086 DBMET00684 | DBMET00684 | |
| 0.005 | 0.771 | 0.068 | HIV-1 integrase inhibitor | 0.068 0.051 DBMET00684 | DBMET00684 | |
| 0.033 | 0.804 | 0.321 | Sodium/bile acid cotransporter inhibitor | 0.263 0.115 DBMET00806 0.2 0.188 DBMET00681 0.321 0.061 DBMET00684 | DBMET00684 | |
| 0.03 | 0.807 | 0.266 | Apoptosis antagonist | 0.231 0.146 DBMET00806 0.266 0.112 DBMET00684 | DBMET00684 | |
| 0.03 | 0.823 | 0.32 | Caspase 3 stimulant | 0.32 0.07 DBMET00684 | DBMET00684 | |
| 0.009 | 0.805 | 0.188 | Vasodilator | 0.188 0.115 DBMET00684 | DBMET00684 | |
| 0.016 | 0.83 | 0.468 | Apoptosis agonist | 0.306 0.168 DBMET00804 0.468 0.085 DBMET00684 | DBMET00684 | |
| 0.011 | 0.864 | 0.149 | Platelet adhesion inhibitor | 0.148 0.108 DBMET00806 0.149 0.106 DBMET00684 | DBMET00684 | |
| 0.005 | 0.895 | 0.177 | Tumour necrosis factor alpha release inhibitor | 0.177 0.129 DBMET00684 | DBMET00684 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |